地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:18771997407
传真:18995651644
邮箱:sales@amyjet.com
<艾美捷科技代理Akina品牌全系列产品
Akina, Inc. 于2001年成立,是一家具有多年经营历史的公司,PolyScitech作为其旗下部门,依托公司的资源和平台开展业务。由Kinam Park博士创立,他是普渡大学生物医学工程与药剂学教授。Kinam Park博士在相关学术领域具有深厚的造诣和丰富的经验,这为PolyScitech部门在技术研发和专业方向上提供了坚实的学术支持和引领。Akina公司的产品线包括:PolySciTech Polymers、PURASORB® Polymers、Viatel™m Polymers、VIVOS™ PLGA-g-PEG、PLGA/PLA Standards、NuPlonTm、AquaGel@ Hydrogels、PET Prepolymer、Flamma Fluor Fluorescent Dyes、Kitopure Chitosan、3DCellMaker。
Akinalytics作为Akina, Inc.的部门,专门从事控释药物输送系统以及可生物降解聚合物及其制药/生物医学应用。提供快速周转和具有竞争力的价格的样品分析,包括FTIR分光光度法、紫外/可见分光光度法、GPC、调制差示扫描量热法、流变分析、机械/纹理分析、光学分析等。

▍Akina公司产品线
● PolySciTech Polymers:提供各种类型的聚合物产品,广泛应用于科研和工业领域
● PURASORB® Polymers:由于Corbion和Akina, Inc. (PolySciTech) 之间的分销关系,Purasorb®聚合物现作为研究产品提供,简化开发项目。用于长效注射剂、医疗器械等,为GMP制造的产品提供临床转化的直接途径。
● Viatel™ Polymers:精选开发产品,得益于Ashland和Akina, Inc. (PolySciTech) 之间的分销关系。无最低订购量要求,购买时间快,便利开发需求。
● VIVOS™ PLGA-g-PEG:使用聚丙交酯-乙醇共聚酯-接枝-聚乙二醇组成的快速溶解、可生物降解的热凝胶输送活性药物。由Vivos, Inc.和Akina, Inc.合作开发,简化药物递送开发。
产品应用:这些聚合物产品具有多种应用,包括但不限于阴离子药物/核酸衍生物的递送;纳米通道和纳米孔的形成;形成“隐形”聚乙二醇化微粒;聚合物混合物的塑化(不溶性);用于改性/交联的短链树脂;热凝胶化;药物的水溶性
▍Akina部分产品列表
<| 货号 | 品名 | 规格 | Mw |
| AK001 | Methoxy poly(ethylene glycol)-b-poly(caprolactone) | 5g;10g;25g | ~2,000:5,200 Da |
| AK002 | Methoxy poly(ethylene glycol)-b-poly(lactide-co-glycolide) | 5g;10g;25g | ~2,000:4,110 Da |
| AK003 | Methoxy poly(ethylene glycol)-b-poly(L-lactide) | 5g;10g;25g | ~2,000:1,700 Da |
| AK004 | Methoxy poly(ethylene glycol)-b-poly(L-lactide) | 5g;10g;25g | ~2,000:5,000 Da |
| AK005 | Methoxy poly(ethylene glycol)-b-poly(L-lactide) | 5g;10g;25g | ~2,000:10,000 Da |
| AK006 | Methoxy poly(ethylene glycol)-b-poly(L-lactide) | 5g;10g;25g | ~750:5,600 Da |
| AK007 | Methoxy poly(ethylene glycol)-b-poly(L-lactide) | 5g;10g;25g | ~5,000:4,900 Da |
| AK008 | Poly(L-lactide)-b-poly(ethylene glycol)-b-poly(L-lactide) | 5g;10g;25g | ~2,400:2,000:2,400 Da |
| AK009 | Methoxy poly(ethylene glycol)-b-poly(D,L-lactide) | 5g;10g;25g | ~2,000:2,200 Da |
| AK010 | Methoxy poly(ethylene glycol)-b-poly(lactide-co-glycolide) | 5g;10g;25g | ~5,000:10,000 Da |
| AK011 | Poly(lactide-co-glycolide)-b-poly(ethylene glycol)-b-poly(lactide-co-glycolide) | 5g;10g;25g | ~1,600:1,000:1,600 Da |
| AK012 | Poly(lactide-co-glycolide)-b-poly(ethylene glycol)-b-poly(lactide-co-glycolide) | 5g;10g;25g | ~1,000:1,000:1,000 Da |
| AK013 | Poly(lactide-co-glycolide)-b-poly(ethylene glycol)-b-poly(lactide-co-glycolide) | 5g;10g;25g | ~2,000:400:2,000 Da |
| AK014 | Poly(lactide-co-glycolide)-b-poly(ethylene glycol)-b-poly(lactide-co-glycolide) | 5g;10g;25g | ~400:400:400 Da |
| AK015 | Poly(lactide-co-glycolide)-b-poly(ethylene glycol)-b-poly(lactide-co-glycolide) | 5g;10g;25g | ~5,000:1,000:5,000 Da |
| AK016 | Poly(lactide-co-glycolide)-b-poly(ethylene glycol)-b-poly(lactide-co-glycolide) | 5g;10g;25g | ~70,000:4,600:70,000 Da |
| AK019 | Poly(lactide-co-glycolide)-b-poly(ethylene glycol)-b-poly(lactide-co-glycolide) | 5g;10g;25g | ~1,500:1,500:1,500 Da |
| AK021 | Methoxy poly(ethylene glycol)-b-poly(D,L-lactide) | 5g;10g;25g | ~5,000:50,000 Da |
| AK023 | Methoxy poly(ethylene glycol)-b-poly(lactide-co-glycolide) | 5g;10g;25g | ~2,000:1,500 Da |
| AK024 | Poly(lactide-co-glycolide)-b-poly(ethylene glycol)-b-poly(lactide-co-glycolide) | 5g;10g;25g | ~1,100:1,000:1,100 Da |
| AK025 | Methoxy poly(ethylene glycol)-b-poly(L-lactide) | 5g;10g;25g | ~750:1,000 Da |
| AK026 | Methoxy poly(ethylene glycol)-b-poly(lactide-co-glycolide) | 5g;10g;25g | ~5,000:55,000 Da |
| AK027 | Methoxy poly(ethylene glycol)-b-poly(lactide-co-glycolide) | 5g;10g;25g | ~2,000:15,000 Da |
| AK028 | Poly(lactide-co-caprolactone)-b-poly(ethylene glycol)-b-poly(lactide-co-caprolactone) | 5g;10g;25g | ~5,700:4,600:5,700 Da |
Nanostructured & Amorphous Materials, Inc.致力于纳米材料科技的应用。主要的业务包括:生产、研发、加工纳米级和非结晶材料。
Nanostructured & Amorphous Materials Inc. (NanoAmor) was founded in Los Alamos, New Mexico, USA, in September 2001. We are a leading nanomaterials company involved in all aspects of the business: manufacturing, research and development, processing, supplying and marketing of nanostructured materials and their dispersions.
Nanostructured & Amorphous Materials的主要产品包括:
Application-Oriented Carbon-Nanotubes Products
Carbon Nanotubes & Nanofibers
Carbon Nanotube Dispersions
Elements, Oxides, Carbides & Nitrides Nanoparticles
Fullerene
Graphenes, Graphene Oxides & Graphene Nanoplatelets
Graphene Film
Nanopowder Dispersions
Nanowires & Nanorods
Amorphous Ribbons
Nanocrystalline Ribbons
Amorphous & Nanocrystalline Cores
Amorphous and Nanocrystalline Magnetic Bars
Amorphous & Nanocrystalline Powders
Amorphous Brazing Foils
Superhard Materials
Surface-Modified Oxide Nanoparticles
| 品名 | 货号 | 规格 |
| CNTs Additives for Lithium-ion Battery | 1376YJ | 1kg; |
| Carbon Nanotubes Fibers | 1356YJ | meter; |
| Carbon Nanotubes Papers | 1348YJ | piece; |
| Carbon Nanotubes Films | 1350YJ | piece; |
| Carbon Nanotubes Films | 1351YJ | 咨询 |
| Water-based carbon nanotubes coatings | 1332YJ | kg; |
| Water-based carbon nanotubes coatings | 1333YJ | kg; |
| Antistatic carbon-nanotubes coatings | 1331YJA | kg; |
| Antistatic carbon-nanotubes coatings | 1331YJB | kg; |
| Conductive/heating carbon-nanotubes coatings | 1378YJA | kg; |
| 20wt% CNTs/80wt% ABS Masterbatch | 1335YJ | 1kg; 5kg; 10kg; |
| 25wt% CNTs/75wt% HDPE Masterbatch | 1337YJ | 1kg; 5kg; 10kg; |
| 25wt% CNTs/75wt% HIPS Masterbatch | 1338YJ | 1kg; 5kg; 10kg; |
| 25wt% CNTs/75wt% LLDPE Masterbatch | 1339YJ | 1kg; 5kg; 10kg; |
| 20wt% CNTs/80wt% PA6 Masterbatch | 1340YJ | 1kg; 5kg; 10kg; |
| 20wt% CNTs/80wt% PP Masterbatch | 1341YJ | 1kg; 5kg; 10kg; |
| 0.2 wt% SWCNTs (> 95%, D < 2 nm)/Water Dispersion | 8040YJ | 500g; |
| 0.2 wt% SWCNTs-COOH (> 95%, OD 1-2 nm)/Water Dispersion | 8042YJ | 500g; |
| 2 wt% MWCNTs (> 98%, D 5-15 nm)/Water Dispersion | 8028YJ | 500ml; |
| 2 wt% MWCNTs-COOH (> 98%, D 5-15 nm)/Water Dispersion | 8027YJ | 500 ml; |
| 10 wt% MWCNTs (> 98%, D 30-80 nm)/Water Dispersion | 8030YJ | 500 ml; |
| 10 wt% MWCNTs-COOH (>98%, D 30-80 nm)/Water Dispersion | 8029YJ | 500 ml; |
| 0.2 wt% SWCNTs (> 95%, D < 2 nm)/Water Paste | 8038YJ | kg; |
| 0.2 wt% SWCNTs-COOH (> 95%, OD 1-2 nm)/Water Paste | 8039YJ | 500g; kg; |
| 2 wt% MWCNTs (> 95%, D 5-15 nm)/Water Paste | 8032YJ | kg; |
| 2 wt% MWCNTs-COOH (> 95%, D 5-15 nm)/Water Paste | 8033YJ | kg; |
| 10 wt% MWCNTs (> 95%, D 30-80 nm)/Water Slurry | 8034YJ | kg; |
| 10 wt% MWCNTs-COOH (> 95%, D 30-80 nm)/Water Paste | 8035YJ | kg; |
| 12-14 wt% MWCNTs (> 95%, D 30-80 nm)/Water Paste | 8036YJ | kg; |
| 12-14 wt% MWCNTs-COOH (>95%, D 30-80 nm)/Water Paste | 8037YJ | kg; |
| 0.2-0.3 wt% SWCNTs (> 95%, D 1-2 nm)/BA Dispersion | 8116YJ | 500 ml; |
| 0.2-0.3 wt% SWCNTs (> 95%, D 1-2 nm)/DMAC Dispersion | 8118YJ | 500 ml; |
| 0.2-0.3 wt% SWCNTs (> 95%, D 1-2 nm)/DMF Dispersion | 8115YJ | 500 ml; |
| 0.2-0.3 wt% SWCNTs (> 95%, D 1-2 nm)/IPA Dispersion | 8117YJ | 500 ml; |
| 0.2-0.3 wt% SWCNTs (> 95%, D 1-2 nm)/NMP Dispersion | 8114YJ | 500 ml; |
| 3 wt% MWCNTs (> 98%, D 5-15 nm)/BA Dispersion | 8124YJ | 500 ml; |
| 8-10 wt% MWCNTs (> 98%, D 30-80 nm)/BA Dispersion | 8123YJ | 500 ml; |
| 3 wt% MWCNTs (> 98%, D 5-15 nm)/DMAC Dispersion | 8126YJ | 500 ml; |
| 10 wt% MWCNTs (> 98%, D 30-80 nm)/DMAC Dispersion | 8125YJ | 500 ml; |
| 3 wt% MWCNTs (> 98%, D 5-15 nm)/DMF Dispersion | 8122YJ | 500 ml; |
| 10 wt% MWCNTs (> 98%, D 30-80 nm)/DMF Dispersion | 8121YJ | 500 ml; |
| 3 wt% MWCNTs (> 98%, D 5-15 nm)/IPA Dispersion | 8130YJ | 500 ml; |
| 8-10 wt% MWCNTs (> 98%, D 30-80 nm)/IPA Dispersion | 8129YJ | 500 ml; |
| 3 wt% MWCNTs (> 98%, D 5-15 nm)/NMP Dispersion | 8120YJ | 500 ml; |
| 5 wt% MWCNTs (> 98%, D 30-80 nm)/NMP Dispersion | 8119YJ | 500 ml; |
| 3 wt% MWCNTs (> 98%, D 5-15 nm)/PMA Dispersion | 8128YJ | 500 ml; |
| 10 wt% MWCNTs (> 98%, D 30-80 nm)/PMA Dispersion | 8127YJ | 500 ml; |
| Fullerence powder (C60, 95+%) | 8072YJ | 1g; 5g; |
| Fullerence powder (C60, 98+%) | 8073YJ | 1g; 5g; |
| Fullerence powder (C60, 99+%) | 8074YJ | 1g; 5g; |
| Fullerene powder (C60, 99.5+%) | 8075YJ | 1g; 5g; |
| Fullerene powder (C60, 99.9+%) | 8076YJ | 1g; 5g; |
| Fullerence powder (C70, 95+%) | 8077YJ | 1g; 5g; |
| Fullerence powder (C70, 98+%) | 8078YJ | 1g; 5g; |
| Fullerence powder (C70, 99+%) | 8079YJ | 1g; 5g; |
| Fullerenol Powder (hydroxylated fullerence C60) | 8080YJ | 1g; 10g; |
| Three-Dimensional Graphene (> 60 wt%, D 6-8 um, 3-4 layers) | 8109YJ | 1g; 5g; |
| 1.0-1.5 wt% Graphenes (> 98 wt%, Dia. 4-6 um, < 10 layers)/NMP paste | 8064YJ | 1g (graphene); 5g (graphene); |
| Highly Elastic Graphene Aerogel (Dia. 2.0 cm, Height 2.0 cm) | 8095YJ | 1 cylinder; 5 cylinders; |
| Ultra-light Graphene Aerogel (Dia. 2.0 cm, Height 2.0 cm) | 8093YJ | 1 cylinder; 5 cylinders; |
| Carbon Nanotubes (10 wt%) Doped Graphene Aerogel (Dia. 1.2 cm, Height 1.2 cm) | 8090YJ | 1 cylinder; 5 cylinders; |
| Carbon Nanotubes (10 wt%) Doped Graphene Aerogel (Dia. 2.0 cm, Height 2.0 cm) | 8091YJ | 1 cylinder; 5 cylinders; |
| Magnetic Graphene Aerogel (47 wt% Fe3O4, Dia. 1 cm, Height 1 cm) | 8096YJA | 1 cylinder; 5 cylinders; |
| Magnetic Graphene Aerogel (47 wt% Fe3O4, Dia. 2 cm, Height 2 cm) | 8096YJB | 1 cylinder; 5 cylinders; |
| Magnetic Graphene Aerogel (63 wt% Fe3O4, Dia. 1 cm, Height 1 cm) | 8097YJA | 1 cylinder; 5 cylinders; |
| Magnetic Graphene Aerogel (63 wt% Fe3O4, Dia. 2 cm, Height 2 cm) | 8097YJB | 1 cylinder; 5 cylinders; |
| Graphene Foam on Nickel Foam (thickness 1-1.2 mm) | 1319YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene Foam (nickel foam etched, thickness 1-1.2 mm) | 1320YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| 1-3 wt% Graphene Oxide (> 98 wt%, D 1-5 um, 1-2 layers)/Water Gel, pH = 3-4 | 8047YJB34 | 1g (graphene oxide); 5g (graphene oxide); |
| Graphene Oxide Paper (Dia. 9 cm, thickness 10 um) | 8089YJ | 1 piece; 5 pieces; |
| Industrial-Grade Graphene Nanoplatelets (> 90 wt%, D 2-13 um, < 30 layers) | 8055YJ2 | 50g; 250g; 1kg; |
| 5 wt% Graphene Nanoplatelets (> 90 wt%, D 2-16 um, < 30 layers)/NMP Paste | 8059YJ | kg (paste); |
| Industrial-Grade Graphene-Nanoplatelets/Carbon-Nanotubes Composites (> 90 wt%) | 8071YJ | 50g; 100g; |
| 5 wt% (Graphene Nanoplatelets & Carbon Nanotubes)/Water Paste | 8060YJ | kg (paste); |
| 5 wt% (Graphene Nanoplatelets & Carbon Nanotubes)/NMP Paste | 8061YJ | kg (paste); |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 97% area covered | 1304YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 97% area covered | 1304YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 97% area covered | 1304YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 97% area covered | 1304YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 97% area covered | 1304YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 85% area covered | 1305YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 85% area covered | 1305YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 85% area covered | 1305YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 85% area covered | 1305YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 85% area covered | 1305YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layers) graphene/copper substrate | 1306YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layers) graphene/copper substrate | 1306YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layers) graphene/copper substrate | 1306YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layers) graphene/copper substrate | 1306YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layers) graphene/copper substrate | 1306YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/PVC substrate, > 97% area covered | 1307YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/PVC substrate, > 97% area covered | 1307YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/PVC substrate, > 97% area covered | 1307YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/PVC substrate, > 85% area covered | 1308YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/PVC substrate, > 85% area covered | 1308YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/PVC substrate, > 85% area covered | 1308YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layer) graphene/PVC substrate | 1309YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layer) graphene/PVC substrate | 1309YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layer) graphene/PVC substrate | 1309YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 97% area covered | 1310YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 97% area covered | 1310YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 97% area covered | 1310YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 97% area covered | 1310YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 85% area covered | 1311YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 85% area covered | 1311YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 85% area covered | 1311YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 85% area covered | 1311YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on silicon-oxide substrate | 1312YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on silicon-oxide substrate | 1312YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on silicon-oxide substrate | 1312YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on silicon-oxide substrate | 1312YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Single-layered graphene on quartz substrate, > 97% area covered | 1313YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Single-layered graphene on quartz substrate, > 97% area covered | 1313YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Single-layered graphene on quartz substrate, > 97% area covered | 1313YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on quartz substrate, > 85% area covered | 1314YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on quartz substrate, > 85% area covered | 1314YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on quartz substrate, > 85% area covered | 1314YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on quartz substrate | 1315YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on quartz substrate | 1315YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on quartz substrate | 1315YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 97% area covered | 1316YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 97% area covered | 1316YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 97% area covered | 1316YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 97% area covered | 1316YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 85% area covered | 1317YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 85% area covered | 1317YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 85% area covered | 1317YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 85% area covered | 1317YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on PET substrate | 1318YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on PET substrate | 1318YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on PET substrate | 1318YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on PET substrate | 1318YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Graphene Foam on Nickel Foam (thickness 1-1.2 mm) | 1319YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene Foam on Nickel Foam (thickness 1-1.2 mm) | 1319YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene Foam on Nickel Foam (thickness 1-1.2 mm) | 1319YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene Foam on Nickel Foam (thickness 1-1.2 mm) | 1319YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene on PVC (nickel foam removed) | 1320YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene on PVC (nickel foam removed) | 1320YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene on PVC (nickel foam removed) | 1320YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene on PVC (nickel foam removed) | 1320YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Silver Nanopowder (Ag, 99.9+%, 20 nm) 0.1 - 1 wt% Dispersion in Water with Anionic Surfactant | 7031HW | 500ml; 1L; |
| Silver Nanopowder (Ag, 99.9+%, 50 nm) 0.1 - 1 wt% Dispersion in Water with Anionic Surfactant | 7033HW | 500ml; |
| Silver Nanopowder (Ag, 99.9+%, 100 nm) 0.1 - 1 wt% Dispersion in Water with Anionic Surfactant | 7035HW | 500ml; |
| Silver Nanopowder (Ag, 99.9+%, 200 nm) 0.1 - 1 wt% Dispersion in Water with Anionic Surfactant | 7038HW | 500ml; |
| Gold Nanopowder (Au, 99.99%, 20 nm) 0.1 - 1 wt% Dispersion in Water | 7041HW | 500ml; |
| Platinum Nanopowder (Pt, 99.9+%, 20-30nm) 0.1wt% Dispersion in Water | 0488HW | 500ml; |
| Palladium Nanopowder (Pd, 99.99%, 20 nm) 0.1 - 1 wt% Dispersion in Water | 7051HW | 500ml; |
| Palladium Nanopowder (Pd, 99.9+%, 10 nm) 0.1wt% Dispersion in Water | 0466HW | kg; |
| Germanium Nanopowder (Ge, 99.9+%, 400 nm) Dispersed in 850ml of Ethanol | 0388HW | 咨询 |
| Aluminum Oxide (alpha, 20 wt%, 30-60nm) in Water | 7017WJWA | 1kg; |
| Aluminum Oxide (gamma, 20 wt%, 30 nm) in Water | 7017WJWG | 1kg; |
| Aluminum Oxide (gamma, 20 wt%, 10 nm) in water | 7016WJWG | 1kg; |
| CuO, 1 wt%, in water, APS 30 nm | 9019WJ | kg; |
| Silicon Oxide (15 wt%, 30 nm) in water | 7019WJ | 30kg; |
| Silicon Oxide (25 wt%, 30 nm) in water | 7015WJ | 1kg; |
| Silicon Oxide (25 wt%, 30 nm) in water | 7016WJ | 1kg; 10kg; |
| Titanium Oxide (Rutile, 40 wt%, 30-50 nm) in water | 7013WJWR | 1kg; |
| Titanium oxide TiO2 (40wt%, Rutile, 30-50 nm ) in Isopropanol | 5006WJ | kg; |
| Titanium Oxide (TiO2, Rutile, >99.5%, 5-30 nm,15 wt%) in water | 7012WJWR | 1kg; |
| Titanium Oxide (Anatase, 20 wt%, 5-30 nm) in IPA | 7014WJWA | 1kg; |
| Titanium Oxide (Anatase, ATO doped, 20 wt%, 15-25 nm) Slurry | 7030WJ | 5kg; |
| Titanium Oxide (Anatase, 20 wt%, 5-30 nm) in water | 7012WJWA | 1kg; |
| Titanium Oxide (Anatase, 15 wt%, 5-30 nm) in water | 7011WJWA | 1kg; |
| Titanium Oxide (TiO2, Anatase, >99.5%, 15 nm, 15 wt%) in water, negatively charged | 7011WJWANC | 咨询 |
| Titanium Oxide Nanopowder (anatase, 5 wt%, 10-20 nm) in ethanol | 7019HT | 1L; 5L; |
| Zinc Oxide (20 wt%, 40 nm) in water | 7006WJ | 1L |
| Indium Tin Oxide (ITO, 30 wt%, 20-30 nm) in Water | 7026HZW | 100g; |
| Silver nanowires (Dia. 70 - 80 nm, Length > 10 um) | 0475HW6 | 1 g (silver nanowires); 5 g (silver nanowires); |
| Silver nanowires (Dia. 30 - 50 nm, Length > 10 um) | 0475HW5 | 1 g (silver nanowires); 5 g (silver nanowires); |
| Silver Nanowires (Dia. 20 - 30 nm, Length > 10 um) | 0475HW4 | 1 g (silver nanowires); 5 g (silver nanowires); |
| Silver nanowires (D = 14-31 nm, L = 5-40 um, 99.95+%, 1 wt% Ag in ethanol) | 0475NW2E | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 14-31 nm, L = 5-40 um, 99.95+%, 1 wt% Ag in isopropanol) | 0475NW2I | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 14-31 nm, L = 5-40 um, 99.95+%, 1 wt% Ag in water) | 0475NW2W | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 25-35 nm, L = 15-25 um, 99.95+%, 1 wt% Ag in ethanol) | 0475NW3E | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 25-35 nm, L = 15-25 um, 99.95+%, 1 wt% Ag in isopropanol) | 0475NW3I | 1 g (Ag nanowires); 2 g (Ag nanowires); 3 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 25-35 nm, L = 15-25 um, 99.95+%, 1 wt% Ag in water) | 0475NW3W | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 35-45 nm, L = 10-20 um, 99.95+%, 1 wt% Ag in ethanol) | 0475NW5E | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 35-45 nm, L = 10-20 um, 99.95+%, 1 wt% Ag in isopropanol) | 0475NW5I | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 35-45 nm, L = 10-20 um, 99.95+%, 1 wt% Ag in water) | 0475NW5W | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 55-75 nm, L = 20-40 um, 99.95+%, 1 wt% Ag in ethanol) | 0475NW6E | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 55-75 nm, L = 20-40 um, 99.95+%, 1 wt% Ag in isopropanol) | 0475NW6I | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 55-75 nm, L = 20-40 um, 99.95+%, 1 wt% Ag in water) | 0475NW6W | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Single-walled Carbon nanotubes - 60%SWNTs (90%CNTs) | 1283YJ | 1g; 5g; |
| SWNT-OH (90% CNTs, 60% SWNTs) | 1285YJF | 1g; 5g; |
| SWNT-COOH (90% CNTs, 60% SWNTs) | 1287YJF | 1g; 5g; |
| Short SWNTs (90% CNTs, 60% SWNTs) | 1281YJS | 1g; 5g; |
| SWNT-OH (> 60%, OD 1-2 nm, Length 1-3 um) | 1285YJFS | 1g; |
| SWNT-COOH (> 60%, OD 1-2 nm, Length 1-3 um) | 1287YJFS | 1g; |
| High-Purity SWNTs (> 95%, OD < 2 nm, Length 5-30 um) | 1288YJ | g; |
| Single-walled carbon nanotubes - 90%SWNTs (95%CNTs) | 1284YJ | g; 5g; |
| SWNT-OH (95% CNTs, 90% SWNTs) | 1286YJF | 1g; |
| SWNT-COOH (95% CNTs, 90% SWNTs) | 1288YJF | 1g; |
| SWCNTs (> 90%, OD 1-2 nm, Length 1-3 um) | 1246YJS | 1g; 5g; |
| Single-Walled Carbon Nanotubes (90+%), -OH Functionalized | 1586YJF | 1g; |
| Single-Walled Carbon Nanotubes (90+%), -COOH Functionalized | 1588YJF | 1g; |
| High-Purity SWNTs (> 95%, OD < 2 nm, Length 5-30 um) | 1288YJ | 1g; |
| High-Purity SWNTs, -OH functionalized (> 95%, OD 1-2 nm, Length 5-30 um) | 1368YJF | 1g; |
| High-Purity SWNTs, -COOH functionalized (> 95%, OD 1-2 nm, Length 5-30 um) | 1369YJF | 1g; |
| High-Purity Short SWNTs (> 95%, OD 1-2 nm, Length 1-3 um) | 1372YJ | 1g; |
| High-Purity Short SWNTs, -OH Functionalized (> 95%, OD 1-2 nm, Length 1-3 um) | 1373YJF | 1g; |
| High-Purity Short SWNTs, -COOH Functionalized (> 95%, OD 1-2 nm, Length 1-3 um) | 1374YJF | 1g; |
| High-Purity SWNTs (> 95%), -NH2 functionalized | 1370YJF | 1g; 5g; |
| High-Purity Short SWNTs (> 95%), -NH2 functionalized | 1371YJFS | 1g; 5g; |
| High-Purity SWNTs (> 95 %, surface area > 1,075 m2/g) | 1300YJ | 1g; |
| DWNTs (> 60%, OD 2-4 nm, Length ~50 um) | 1280YJD | 1g; 5g; 25g; |
| DWNTs-COOH (> 60%, OD 2-4 nm, Length ~50 um) | 1281YJD | g; |
| Multi-Walled Carbon Nanotube -MWNT (98%, OD 4-6 nm) | 1389YJ | 10g; |
| Multi-wall carbon nanotube -MWNT (98%, OD 5-15 nm) | 1203YJ | 10g; 25g; |
| Multi-walled carbon nanotube -MWNT (99%, OD 5-15 nm) | 8101YJ | 10g; |
| Multi-wall carbon nanotube -MWNT (95+%, OD 8-15 nm) | 1204YJ | 10g; |
| Multi-wall carbon nanotube -MWNT (>98%, OD 10-20 nm) | 1205YJ | 10g; |
| Multi-wall carbon nanotube -MWNT (>98%, OD 20-30 nm) | 1229YJ | 10g; |
| Multi-wall carbon nanotube -MWNT (98+%, OD 30-50 nm) | 1231YJ | 10g; |
| Multi-wall carbon nanotube -MWNT (>98%, OD 30-80 nm) | 1233YJ | 10g; 25g; |
| Short MWNT (98+%, OD 4-6 nm, Length 0.5-2 um) | 1392YJS | 5g; |
| Short MWNT (98+%, OD 5-15 nm, Length 0.5-2 um) | 1225YJS | 5g; |
| Short MWNT (99+%, OD 5-15 nm, Length 0.5-2 um) | 8104YJS | 5g; |
| Short MWNT (95+%, OD 8-15 nm, Length 0.5-2 um) | 1235YJS | 5g; |
| Short MWNT (>98%, OD 10-20 nm, Length 0.5-2 um) | 1236YJS | 10g; |
| Short MWNT (98+%, OD 20-30 nm, Length 0.5-2 um) | 1237YJS | 5g; |
| Short MWNT (98+%, OD 30-50 nm, Length 0.5-2 um) | 1238YJS | 5g; |
| Short MWNT (98+%, OD 30-80 nm, Length 0.5-2 um) | 1227YJS | 5g; |
| Graphitized MWNT (99.9%, OD 8-15 nm) | 1219YJ | 10g; 25g; |
| Graphitized MWNT (99.9%, OD 10-20 nm) | 1220YJ | 10g; |
| Graphitized MWNT (99.9%, OD 20-30 nm) | 1221YJ | 5g; |
| Graphitized MWNT (99.9%, OD 30-50 nm) | 1222YJ | 5g; |
| Graphitized MWNT (99.9%, OD 30-80 nm) | 1223YJ | 5g; |
| Industrial-grade MWNT (95+%, OD 4-6 nm) | 1395YJ | 1kg; |
| Industrial-Grade MWNT (95+%, OD 5-15 nm) | 1201YJG | 1kg; |
| Industrial-grade MWNT (95%, OD 8-15 nm) | 1201YJA | 1kg; |
| Industrial-grade MWNT (95+%, OD 10-20 nm) | 1201YJB | 1kg; |
| Industrial-grade MWNT (95+%, OD 10-30 nm) | 1201YJC | 1kg; |
| Industrial-grade MWNT (95+%, OD 20-40 nm) | 1201YJD | 1kg; |
| Industrial-Grade MWNT (95+%, OD 30-80 nm) | 1201YJE | 1kg; |
| MWNT-OH (98+%, OD 4-6 nm) | 1390YJF | 10g; |
| MWNT-OH (98+%, OD 5-15 nm) | 1261YJF | 5g; |
| MWNT-OH (99+%, OD 5-15 nm) | 8103YJF | 5g; |
| MWNT-OH (95+%, OD 8-15 nm) | 1262YJF | 5g; |
| MWNT-OH (98+%, OD 10-20 nm) | 1263YJF | 5g; |
| MWNT-OH (98+%, OD 20-30 nm) | 1264YJF | 5g; 25g; 100g; |
| MWNT-OH (98+%, OD 30-50 nm) | 1265YJF | 5g; |
| MWNT-OH (98+%, OD 30-80 nm) | 1266YJF | 5g; |
| Short MWNT-OH (98+%, OD 4-6 nm, Length 0.5-2 um) | 1393YJF | 5 g; 100 g; |
| Short MWNT-OH (98+%, OD 5-15 nm, Length 0.5-2 um) | 1247YJF | 5g; |
| Short MWNT-OH (99+%, OD 5-15 nm, Length 0.5-2 um) | 8106YJF | 5g; |
| Short MWNT-OH (95+%, OD 8-15 nm, Length 0.5-2 um) | 1248YJF | 5g; |
| Short MWNT-OH (98+%, OD 10-20 nm, Length 0.5-2 um) | 1249YJF | 5g; |
| Short MWNT-OH (98+%, OD 20-30 nm, Length 0.5-2 um) | 1251YJF | 5g; |
| Short MWNT-OH (98+%, OD 30-50 nm, Length 0.5-2 um) | 1252YJF | 5g; |
| Short MWNT-OH (98+%, OD 30-80 nm, Length 0.5-2 um) | 1253YJF | 1g; 5g; |
| Graphitized MWNT-OH (99.9%, OD 8-15 nm) | 1224YJF | 1g; |
| Graphitized MWNT-OH (99.9%, OD 10-20 nm) | 1228YJF | 1g; 5g; |
| Graphitized MWNT-OH (99.9%, OD 20-30 nm) | 1235YJF | 1g; 5g; |
| Graphitized MWNT-OH (99.9%, OD 30-50 nm) | 1239YJF | 1g; 5g; |
| Graphitized MWNT-OH (99.9%, OD 30-80 nm) | 1240YJF | 1g; 5g; |
| Industrial-grade MWNT-OH (95+%, OD 5-15 nm) | 1201YJI | 1kg; |
| Industrial-grade MWNT-OH (95+%, OD 8-15 nm) | 1201YJL | 1kg; |
| Industrial-grade MWNT-OH (95+%, OD 10-30 nm) | 1207YJF | 1kg; |
| Industrial-grade MWNT-OH (95+%, OD 20-40 nm) | 1208YJF | 1kg; |
| Industrial-grade MWNT-OH (95+%, OD 30-80 nm) | 1209YJF | 1kg; |
| MWNT-COOH (98+%, OD 4-6 nm) | 1391YJF | 10g; |
| MWNT-COOH (98+%, OD 5-15 nm) | 1267YJF | 5g; |
| MWNT-COOH (99+%, OD 5-15 nm) | 8102YJF | 10g; |
| MWNT-COOH (95+%, OD 8-15 nm) | 1268YJF | 5g; |
| MWNT-COOH (98+%, OD 10-20 nm) | 1269YJF | 5g; |
| MWNT-COOH (98+%, OD 20-30 nm) | 1270YJF | 5g; |
| MWNT-COOH (98+%, OD 30-50 nm) | 1271YJF | 5g; |
| MWNT-COOH (98+%, OD 30-80 nm) | 1272YJF | 5g; |
| Short MWNT-COOH (98+%, OD 4-6 nm, Length 0.5-2 um) | 1394YJF | 5g; |
| Short MWNT-COOH (98+%, OD 5-15 nm, Length 0.5-2 um) | 1254YJF | 5g; |
| Short MWNT-COOH (99+%, OD 5-15 nm, Length 0.5-2 um) | 8105YJF | 5g; |
| Short MWNT-COOH (95+%, OD 8-15 nm, Length 0.5-2 um) | 1255YJF | 1g; 5g; |
| Short MWNT-COOH (98+%, OD 10-20 nm, Length 0.5-2 um) | 1256YJF | 5g; |
| Short MWNT-COOH (98+%, OD 20-30 nm, Length 0.5-2 um) | 1257YJF | 1g; 5g; |
| Short MWNT-COOH (98+%, OD 30-50 nm, Length 0.5-2 um) | 1259YJF | 1g; 5g; |
| Short MWNT-COOH (98+%, OD 30-80 nm, Length 0.5-2 um) | 1273YJF | 1g; 5g; |
| Graphitized MWNT-COOH (99.9%, OD 8-15 nm) | 1241YJF | 10g; |
| Graphitized MWNT-COOH (99.9%, OD 10-20 nm) | 1242YJF | 10g; |
| Graphitized MWNT-COOH (99.9%, OD 20-30 nm) | 1243YJF | 10g; |
| Graphitized MWNT-COOH (99.9%, OD 30-50 nm) | 1244YJF | 1g; 5g; |
| Graphitized MWNT-COOH (99.9%, OD 30-80 nm) | 1245YJF | 1g; 5g; |
| Industrial-grade MWNT-COOH (95+%, OD 5-15 nm) | 1201YJH | 1kg; |
| Industrial-grade MWNT-COOH (95+%, OD 8-15 nm) | 1201YJK | 1kg; |
| Industrial-grade MWNT-COOH (95+%, OD 10-30 nm) | 1210YJF | 1kg; |
| Industrial-grade MWNT-COOH (95+%, OD 20-40 nm) | 1216YJF | 1kg; |
| Industrial-grade MWNT-COOH (95+%, OD 30-80 nm) | 1218YJF | 1kg; |
| Aligned MWNT (98+%, OD 8-15 nm, Length: 30-50 um) | 1215YJA | 25g; |
| Carbon nanofibers (70+%, D = 200-600 nm, L = 5-50 um) | 1177YJ | 10g; |
| Carbon Nanofibers (95+%, D = 50-200 nm, L = 1-15 um) | 8107YJ | 10g; |
| Graphitized carbon nanofibers (95+%, OD = 50-200 nm, L = 1-15 um) | 1178YJ | 10g; |
| Graphene (> 98 wt%, D > 50 um, < 3 layers) | 2191YJ | 1g; 5g; |
| Graphene Oxide (> 99 wt%, D 0.5-3 um, < 3 Layers) | 2192YJ | 1g; 5g; |
| Graphene Nanoplatelets (> 99.5 wt%, D 5-10 um, < 20 layers) | 8056YJ | 1g; 5g; 25g; |
| Industrial-Grade Graphene Nanoplatelets (> 90 wt%, D 2-16 um, < 30 layers) | 8055YJ | 50g; 250g; 1kg; |
| *60% Ni/38% MWNT (95+%, OD 8-15 nm) | 1293YJ | 10g; |
| *60% Ni/38% MWNT (95+%, OD 10-20 nm) | 1294YJ | 10g; |
| *60% Ni/38% MWNT (95+%, OD 20-30 nm) | 1295YJ | 10g; |
| *60% Ni/38% MWNT (95+%, OD 30-50 nm) | 1296YJ | 10g; |
| *60% Ni/38% MWNT (95+%, OD 30-80 nm) | 1297YJ | 10g; |
| MWNT-NH2 (95+%, OD 8-15 nm, 0.45 wt% amino) | 1562YJF | 5g; |
| Nitrogen-doped MWNTs (98%, OD 30-80 nm) | 8054YJ | 5g; |
| Large inner diameter thin-walled multi-walled carbon nanotubes | 1563YJF | 5g; |
| Coiled CNTs (60+%, OD 100-200 nm, Length 1-10 um) | 1298YJ | 5g; |
| Silver Nanopowder (Ag, 99.99%, 400 nm ) | 0487HW | 咨询 |
| Silver Nanopowder (Ag, 99.9%, 200 nm ) | 0479HW | 咨询 |
| Silver Nanopowder (Ag, 99.99%, 100 nm ) | 0489HW | 咨询 |
| Silver Nanopowder (Ag, 99%, 90-210 nm) | 0471CD | 咨询 |
| Silver Nanopowder (Ag, 99.9%, 80 nm ) | 0475HW | 咨询 |
| Silver Nanopowder (Ag, 99.9%, 80 nm, w/~0.3% PVP ) | 0476HW | 咨询 |
| Silver Nanopowder (Ag, 99.9% , 40 nm ) | 0473HW | 咨询 |
| Silver Nanopowder (Ag, 99.9%, 40 nm, w/~0.3% PVP ) | 0474HW | 咨询 |
| Silver Nanopowder (Ag, 99.9%, 30-50 nm, w/0.2 wt% PVP) | 0477YD | 咨询 |
| Silver Nanopowder (Ag, 35 nm, 99.5%, metal basis) | 0476JY | 咨询 |
| Silver Nanopowder (Ag, 99.9% , 20 nm ) | 0477HW | 咨询 |
| Silver Nanopowder (Ag, 99.9%, 20 nm, w/~0.3% PVP ) | 0478HW | 咨询 |
| Aluminum Powder (99.9%, 500 um) | 0156HW | 咨询 |
| Aluminum Powder (99.9%, 50 um) | 0154HW | 咨询 |
| Aluminum Powder (99.9%, 5 um) | 0152HW | 咨询 |
| Aluminum Nanoparticles (99.9%, 500 nm) | 0150HW | 咨询 |
| Aluminum Nanopowder (Al, 99.9+%, 70-80 nm) | 0137HW | 咨询 |
| Aluminum Nanopowder (99.9+%, 70-80 nm, w/PVP) | 0140HW | 咨询 |
| Aluminum Nanopowder (Al, 99.9+%, 40-50 nm) | 0138HW | 咨询 |
| Aluminum Nanopowder (99.9+%, 40-50 nm, w/PVP) | 0139HW | 咨询 |
| Aluminum Nanopowder (Al, 99+%, metal basis, 18 nm) | 0136JY | 咨询 |
| Gold (Au) Nanopowder (99.9%, 50-100 nm) | 0795CD | 咨询 |
| Gold (Au) Nanopowder (25nm, 99.9%) | 8801HW | 咨询 |
| Gold (Au) Nanopowder (10-20 nm, 99.95%) | 8796HW | 咨询 |
| Gold (Au) Nanopowder (10nm, 99.9%) | 8799HW | 咨询 |
| Bismuth Nanopowder (Bi, 99.9%, 80-100 nm) | 0832HW | 咨询 |
| Bismuth Nanopowder (Bi, 99.5%, 40-60 nm) | 0831HW | 咨询 |
| Nano Activated Carbon (C, 88+%, 100 nm) | 1211NH | 咨询 |
| Diamond Nanopowder (synthesized, 55-70%, 4-15nm) | 1311JGY | 咨询 |
| Diamond Nanopowder (synthesized, 98+%, 3-10 nm) | 1321JGY | 咨询 |
| Diamond Nanopowder (synthesized, 97%, 3-6 nm) | 1350SL | 咨询 |
| Graphite Nanopowder (400 nm, 99.9%) | 1250HT | 咨询 |
| *Cobalt Nanopowder, Carbon Coated (Co, 99%, 40 nm) | 0286HW | 咨询 |
| *Cobalt Nanopowder (Passivated, 99.8%, 28 nm) | 0276JY | 咨询 |
| *Chromium Nanopowder (Cr, 99.5%, 50 nm) | 0240XX | 咨询 |
| *Copper Nanopowder (Cu, 99%, 500 nm) | 0293HW | 100g; |
| *Copper Nanopowder (Cu, 99.9%, 200 nm) | 0290HW | 25g; |
| *Copper Nanopowder (Cu, 99.9%, 100 nm) | 0298HW | 25g; |
| *Copper Nanopowder (Partially Passivated, 99+%, 80 nm) | 0294HW | 25g; |
| *Copper Nanopowder (Cu, 99.9%, 70 nm) | 0291HW | 25g; |
| *Copper Nanopowder (Cu, 99.5%, 50-80 nm) | 0292HW | 25g; |
| *Copper Nanopowder (Cu, 99.9%, 40 nm) | 0295HW | 25g; |
| *Copper Nanopowder (Cu, carbon coated, 99.8%, 25 nm) | 0297JY | 5g; |
| *Iron Nanopowder (Fe, 99.9%, 500nm) | 0272YM | 100g; 1kg; |
| *Iron Nanopowder (Fe, 99.9%, 100 nm) | 0264HW | 25g; |
| *Iron Nanopowder (Fe, 99.9%, 70 nm) | 0263HW | 25g; 100g; |
| *Iron Nanopowder (Fe, 99.9%, 40 nm) | 0262HW | 25g; 100g; |
| *Iron nanopowder, carbon coated (Fe/C, 99.6%, 25 nm) | 0267JY | 25g; |
| Germanium Nanopowder (Ge, 99.9+%, 600 nm) | 0327HW | 25g; |
| Germanium Nanopowder (Ge, 99.9%, 500 nm) | 0331HW | 1kg; |
| Germanium Nanopowder (Ge, 99.9+%, 400 nm) | 0326HW | 1kg; |
| Germanium Nanopowder (Ge, 99.9+%, 300 nm) | 0325HW | 1kg; |
| Germanium Nanopowder (Ge, 99.9+%, 200 nm) | 0323HW | 100g; kg; |
| Germanium Nanopowder (Ge, 99.9+%, 150 nm) | 0322HW | 咨询 |
| Germanium Nanopowder (Ge, 99.9+%, < 100 nm) | 0322HH | 咨询 |
| Germanium Nanopowder (Ge, 99.9+%, 20-50 nm) | 0321HW | 5g; |
| Iridium Nanopowder (Ir, 99.95%, 20-30 nm), wet powder in Deionized Water | 0771HW | 咨询 |
| *Molybdenum Nanopowder (Mo, 99.5%, 70 nm) | 0423HW | 咨询 |
| Niobium Nanopowder (Nb, 99.9%, 40-60 nm) | 0411HW | 咨询 |
| *Nickel Nanopowder (Ni, 99%, 800 nm) | 0302HW | 咨询 |
| *Nickel Nanopowder (Ni, 99%, 400 nm) | 0301HW | 100g; 1kg; |
| *Nickel Nanopowder (Ni, 99+%, 300 nm) | 0289HW | 1kg; |
| *Nickel Nanopowder (Ni, 99.5%, 100 nm) | 0285HW | 25g; |
| *Nickel Nanopowder (Ni, 99.9%, 80 nm) | 0284HW | 300g; |
| *Nickel Nanopowder (Ni, 99.5%, 70 nm) | 0288HW | 25g; |
| *Nickel Nanopowder (Ni, 99.5%, 40 nm) | 0283HW | 25g; |
| *Nickel Nanopowder, carbon coated (Ni/C, 99.9%, 20 nm) | 0287JY | 5g; |
| Palladium Nanopowder (Pd, 99.95%, 20-30 nm) | 0462HW | 咨询 |
| Platinum Nanopowder (Pt, 99.95%, 20-30 nm) | 0782HW | 咨询 |
| Platinum Nanopowder, PVP coated (Pt, 99.95%, 20-30 nm) | 0787HW | 1g; |
| Platinum Nanopowder (Pt, 99.9%, 20-30 nm) | 0786HW | 1g; 5g; |
| Rhodium Nanopowder (Rh, 99.95%, 20-30 nm) | 0451HW | 咨询 |
| Ruthenium Nanopowder (Ru, 99.95%, 20-30 nm) | 0441HW | 1g; |
| *Silicon Nanopowder (Si, 99%, 400 nm) | 0144HW | 100g; |
| *Silicon Nanopowder (Si, 99.9%, 100 nm) | 0149HW | 100g; |
| *Silicon Nanopowder (Si, > 97%, 50 nm) | 0145KE | 咨询 |
| *Silicon Nanopowder (Si, 99%, 30-50 nm) | 0147HW | 50g; |
| *Silicon Nanopowder (Si, 98+%, 30-50 nm) | 0141JS | 50g; 100g; 500g; 1kg; |
| Tin Nanopowder (Sn, 70 nm, w/PVP ) | 5522HW | 500g; |
| Tin Nanopowder (Sn, 99.9%, 60-80 nm) | 0501HW | 咨询 |
| *Tantalum Nanopowder (Ta, 99.9%, 40 nm) | 0225HW | 25g; |
| *Tantalum Nanopowder (Ta, 99.9%, 70 nm) | 0224HW | 25g; |
| *Titanium Nanopowder (Ti, 99%, 60-80 nm) | 0227HW | 25g / $361; |
| *Tungsten Powder (W, 99.5+%, 1-2 um) | 0747HW | 100g; |
| *Tungsten Nanopowder (W, 99.5%, 500 nm) | 0749HW | 1kg; |
| *Tungsten Nanopowder (W, 99.5%, <100 nm) | 0745HW | 100g; |
| *Zinc Nanopowder (Zn, 99%, 500 nm) | 0318HW | 1kg; |
| *Zinc Nanopowder (Zn, 99.5%, 130 nm) | 0303HW | 25g; |
| *Zinc Nanopowder (Zn, 99.9+%, 100 nm) | 0306JY | 25g; |
| *Zinc Nanopowder (Zn, 99.5%, 80 nm) | 0304HW | 25g; |
| *Aluminum Nitride Nanopowder (AlN, Amorphous, <0.5um, 99.9%) | 1004HW | 咨询 |
| Aluminum Nitride Nanopowder (AlN, 99.9 %, 0.5 um) | 1005HW | 咨询 |
| *Aluminum Nitride Nanopowder (AlN, 99.5 %, 70-80 nm) | 1002HW | 咨询 |
| Boron Carbide Powder (B4C, 99%, 500 μm) | 1175HW | 咨询 |
| Boron Carbide Powder (B4C, 99%, 50 μm) | 1177HW | 咨询 |
| Boron Carbide Powder (B4C, 99%, 40 μm) | 1179HW | 1kg; |
| Boron Carbide Powder (B4C, 98%, 20μm) | 1172HW | 1kg; |
| Boron Carbide Powder (B4C, 98%, 10μm) | 1169HW | 1kg; |
| Boron Carbide Powder (B4C, 99%, 5 μm) | 1165HW | 1kg; |
| Boron Carbide Powder (B4C, 99%, 2 um) | 1183HW | 1 kg; |
| Boron Carbide Powder (B4C, 99+%, 1-2 μm) | 1162HW | 咨询 |
| Boron Carbide Nanopowder (B4C, 99+%, 500 nm) | 1160HW | 500g; |
| Boron Carbide Nanopowder (B4C, 99%, 50nm) | 1161HY | 100g; |
| Boron Nitride Powder (BN, hexagonal, 99.8%, 0.6-1.2um) | 1182HW | 咨询 |
| Boron Nitride Nanopowder (BN, hexagonal, 99%, 137 nm) | 1180YL | 25g; |
| Boron Nitride Nanoplates (BN, 99.5+%, 100 nm) | 1183NJ | 100g; |
| Chromium Carbide Nanopowder (Cr3C2, 99.9%, <100 nm) | 0247HW | 500g; 1kg; |
| Hafnium Boride Nanopowder (HfB2, 99+%, 60 nm) | 1010JC | 100g; |
| Hafnium Carbide Nanopowder (HfC, 99+%, 200 nm) | 1005JC | 500g; |
| Hafnium Carbide Nanopowder (HfC, 99+%, 60 nm) | 1006JC | 100g; |
| Hafnium Carbide Nanopowder (HfC, 99%, 50nm) | 1022JC | kg; |
| Niobium Carbide Nanopowder (NbC, 99.9%, 500 nm) | 3860YM | 咨询 |
| Silicon Carbide Powder (SiC, 500 um, 99%, Hexagonal) | 4652HW | 1kg; ; |
| Silicon Carbide Powder (SiC, 50 um, 99%, Hexagonal) | 4654HW | 1kg; ; |
| Silicon Carbide Micron Powder (SiC, Beta, 40um, 99+%) | 4645HW | 1kg; ; |
| Silicon Carbide Powder (SiC, Beta, 20um, 99+%) | 4643HW | 1kg; ; |
| Silicon Carbide Powder (SiC, Beta, 10um, 99+%) | 4641HW | 1kg; ; |
| Silicon Carbide Micron Powder (SiC, Beta, 7um, 99+%) | 4639HW | 100g; 1kg; ; |
| Silicon Carbide Powder (SiC, beta, 99.8%, 5 μm) | 4637HW | 100g; ; |
| Silicon Carbide Powder (SiC, beta, 99+%, 2 μm) | 4635HW | 咨询 |
| Silicon Carbide Powder (SiC, alpha, 99.9%, 2um) | 4627HY | 1kg; |
| Silicon Carbide Powder (SiC, 500 nm, 99%, Cubic) | 4656HW | 1kg; ; |
| Silicon Carbide Nanopowder (SiC, beta, 99%, 80-100 nm) | Stock # 4629HW | 100g; |
| Silicon Carbide Nanopowder (SiC, alpha, 99.9%, 55 nm) | 4625HY | 100g; |
| Silicon Carbide Nanopowder (SiC, beta, 97.5%, 45-55 nm) | 4620KE | 200g; |
| Silicon Carbide Nanopowder (SiC, alpha, 99.9%, 30 nm) | 4626HY | 100 g; 150 g; |
| Silicon Carbide Nanowhisker (beta, SiC, 99+%) | 4622HW | 25g; |
| Silicon Nitride Nanopowder (Si3N4, amorphous, 98.5+%, 15-30 nm) | 4750KE | 100g; |
| Titanium Boride Powder (TiB2, 2-12 μm ) | 5180HW | 100g |
| *Titanium Carbide Powder (TiC, 1 micron, 99%) | 5218YL | 500g; |
| *Titanium Carbide Nanoparticles (TiC, 100-200nm, 99+%) | 5217HW | 1kg; |
| Titanium Carbide (TiC, 99+%, 100 nm) | 5217JC | 100g; |
| *Titanium Carbide (TiC, 98+%, 80 nm) | 5220HT | 25g; 100g; |
| *Titanium Carbide Nanopowder (TiC, 97+%, 50 nm) | 5216KE | 100g; |
| *Titanium Nitride Powder (TiN, 99%, 1-3um) | 5352JC | 500g; 1kg; |
| *Titanium Nitride Nanoparticles (TiN, 99%, 100-200 nm) | 5357HW | 500g; |
| *Titanium Nitride Nanopowder (TiN, 97+%, 20 nm) | 5350KE | 100g; |
| Tungsten Carbide/Cobalt Nanopowder (8wt%Co/WC, < 200 nm, 99.5%) | 5561HW | 100g |
| Zirconium Carbide Nanopowder (ZrC, 99%, 8 um) | 5905KE | 100g; 250g; 500g; |
| *Zirconium Carbide Nanopowder (ZrC, 97%, 60 nm) | 5901KE | 100g; |
| *Zirconium Nitride Nanopowder (ZrN, 99.5%, 1-3um) | 6101JC | 500g; kg; |
| Zirconium Boride Nanopowder (ZrB2, 99%, 60 nm) | 5950JC | 100g; |
| Aluminum Oxide (Al2O3) Nanopowder (alpha, 99.9+%, 500 nm) | 1037HT | 100g; |
| Aluminum Oxide (Al2O3) Nanopowder (alpha, 99+%, 500 nm) | 1038HT | 100g; |
| Aluminum Oxide Nanopowder (alpha, aluminate coated, 98+%, 500 nm) | 1039HT | 100g; |
| Aluminum Oxide (Al2O3) Nanopowder (alpha, 99.9%, 200 nm) | Stock #:1040LQS | 100g |
| Aluminum Oxide (Al2O3) Nanopowder (alpha, 99.9%, 150 nm) | 1005MR | 100g ; |
| Aluminum Oxide (Al2O3) Nanopowder (alpha, 99.9+%, 40-50 nm) | 1044HT | 100g; |
| Aluminum Oxide (Al2O3) Nanopowder (alpha/theta, 99.99%, ~30nm ) | 1018WJ | 100g ; |
| Aluminum Oxide (Al2O3) Nanopowder (gamma, 99+%, 500 nm) | 1045HT | 100g; |
| Aluminum Oxide (Al2O3) Nanopowder (gamma, 99.97%, 20-30 nm) | 1020MR | 100g; 500g; 1kg; |
| Aluminum Oxide Nanopowder (gamma, 99.5%, 50 nm) | 1007XX | 咨询 |
| Aluminum Oxide (Al2O3) Nanopowder (gamma, 99.99%, 10 nm) | 1043HT | 100g; |
| Aluminum oxide nanopowder, (γ-phase) APS 20-30 nm, 99.95+% | 0125HW | 咨询 |
| Aluminum Oxide Nanopowder ( 99.99%, 30 nm ) for Lithium Batteries | 1016WJ | 咨询 |
| Aluminum Hydroxide Nanopowder (99.5 %, 50 nm) | 1040WJ | 咨询 |
| Boron Oxide Nanopowder (B2O3, 98%, 40-80 nm) | 1185DF | 咨询 |
| Boron Oxide Nanopowder (B2O3, 99%, 40-80 nm) | 1186DF | 1kg; |
| Bismuth Oxide Nanopowder (Bi2O3 , 99.9%, 100 nm) | 1171HT | kg; |
| Cerium Oxide, (CeO2, 99.99%, 200 nm) | 1445MG | 100g; |
| Cerium Oxide Nanopowder (CeO2, 99%, 50-100 nm) | 1408HW | 100g; |
| Cerium Oxide (CeO2, 99.99%, 20-30 nm) | 1444ZQ | 100g; |
| Cerium Oxide Nanopowder (CeO2, 99.9%, 15-30 nm) | 1406RE | 100g; |
| Cobalt(II,III) Oxide Nanopowder (Co3O4, 99%, 50-80 nm) | 1720HT | 咨询 |
| Chromium Oxide Powder (Cr2O3, 99.8%, 1 um) | 1920FY | 25g; 1kg; |
| Chromium Oxide Powder (Cr2O3, 99.9%, 100 nm) | 1925FY | 100g; 1kg; |
| Chromium Oxide Nanopowder (Cr2O3, 99+%, 60 nm) | 1910FY | 25g; |
| Copper(II) Oxide Nanopowder (CuO, 99+%, 30-50 nm) | 2110FY | 咨询 |
| Copper(I) Oxide Nanopowder (Cu2O, 99%, 30-50 nm) | 2113HW | 25g; 100g; 500g; 1kg; |
| Dysprosium Oxide Nanopowder (Dy2O3, 99.9%, 55 nm) | 2252YS | 25g; |
| Dysprosium Oxide Nanopowder (Dy2O3, 99.9%, 30-70 nm) | 2253ZQ | 25g; |
| Erbium Oxide Nanopowder (Er2O3, 99.9%, 43 nm) | 2310ZQ | 65g; |
| Erbium Oxide Nanopowder (Er2O3, 99.9%, 41-53 nm) | 2350YS | 25g; |
| Erbium Oxide Nanopowder (Er2O3, 99.9%, 20-30 nm) | 2330RE | 25g ; |
| Europium Oxide Nanopowder (Eu2O3, 99.995%, 58 nm) | 2410ZQ | 5g; |
| Europium Oxide Nanopowder (Eu2O3, 99.99%, 45-58 nm) | 2450YS | 5g; |
| Europium Oxide Nanopowder (Eu2O3, 99.99%, 30-50 nm) | 2411RE | 5g; |
| Iron(III) Oxide Nanopowder (Fe2O3, gamma, 99.98%, 50 nm) | 2527YM | 1kg |
| Iron(III) Oxide Nanopowder (Fe2O3, alpha, 99%, 30-50 nm) | 2520ZH | 25g; 100g; |
| Iron(III) Oxide Nanopowder (Fe2O3, alpha, 99%, 30 nm) | 2525WJ | 100g; |
| Iron(II,III) Oxide Nanopowder (Fe3O4, 99%, 100-200 nm) | 2653HW | 100g; |
| Iron(II,III) Oxide Nanopowder (Fe3O4, 97%, 50-100 nm) | 2650TS | 100g; |
| Iron(II,III) Oxide Nanopowder (Fe3O4, 99%, SSA: 9-14 m2/g, 50-100 nm) | 2655HW | 100g; 500g; 1kg; |
| Iron(II,III) Oxide Nanopowder (Fe3O4, 99%, 30 nm) | 2651WJ | 100g; |
| Iron Oxide Nanopowder (Fe3O4, PVP coated, 99+%, 20-30 nm) | 2657HW | 100g; 1kg; |
| Gadolinium Oxide Nanopowder (Gd2O3, 99.9+%, 20-80 nm) | 2680ZQ | 咨询 |
| Gadolinium Oxide Nanopowder (Gd2O3, 99.9%, 15-30 nm) | 2681RE | 咨询 |
| Hafnium Oxide Powder (HfO2, 99.99%, 48um) | 1045HW | 咨询 |
| Hafnium Oxide Powder (HfO2, 99%, 45um) | 1042HW | 咨询 |
| Indium Oxide Nanopowder (In2O3, 99.99%, 100-200 nm) | 2711TN | 咨询 |
| Indium Hydroxide Nanopowder (In(OH)3, 99.99%, 20-70 nm) | 2810TN | 咨询 |
| Lanthanum Oxide Nanopowder (La2O3, 99%, 50 nm) | 2922RE | 咨询 |
| Lanthanum Oxide Nanopowder (La2O3, 99.99%, 15-30 nm) | 2920RE | 咨询 |
| Magnesium Oxide Nanopowder (MgO, 99+%, 40-60 nm) | 3305HT | 咨询 |
| Neodymium Oxide Nanopowder (Nd2O3, 99.9%, 40nm) | 3912RE | 1kg; |
| Magnesium Oxide Nanopowder (MgO, 99+%, 40 nm) | 3304HT | 咨询 |
| Magnesium Hydroxide Nanopowder (Mg(OH)2, 98+%, 100 nm) | 3321HT | 咨询 |
| Molybdenum(VI) Oxide Nanopowder (MoO3 , 99.5%, 100 nm) | 3851XW | 咨询 |
| Neodymium Oxide Nanopowder (Nd2O3, 99.9+%, 83 nm) | 3910ZQ | 咨询 |
| Neodymium Oxide Nanopowder (Nd2O3, 99.9%, 49-64 nm) | 3950YS | 咨询 |
| Neodymium Oxide Nanopowder (Nd2O3, 99.9%, 40nm) | 3912RE | 咨询 |
| Neodymium Oxide Nanopowder (Nd2O3, 99.9%, 15-30 nm) | 3911RE | 25g; |
| Nickel Oxide Nanopowder (Ni2O3, 99.9%, 20-30 nm) | 4216HW | 100g; |
| Praseodymium Oxide Nanopowder (Pr6O11, 99.9%, 15-30 nm) | 4451RE | 25g; |
| Antimony Oxide Nanoparticles (Sb2O3, 99.99%, 20-30nm) | 6850HW | 咨询 |
| Silicon Oxide Powder (SiO2 , quartz, 99.99%, 1-3.5 μm) | 4856WG | 咨询 |
| Silicon Oxide Powder (SiO2 , quartz, 99.998%, 1-3.5um) | 4855WG | 咨询 |
| Silicon Oxide Nanopowder (SiO2 , 99+%, 20 nm) | 4830HT | 咨询 |
| Silicon Oxide Nanopowder (99+%, 20 nm, hydrophilic & lipophilic) | 4831HT | 咨询 |
| Silicon Oxide Nanopowder (99+%, 20 nm, hydrophilic & lipophilic) | 4832HT | 咨询 |
| Silicon Oxide Nanopowder (99+%, 20 nm, hydrophilic & lipophilic) | 4833HT | 咨询 |
| Samarium Oxide Nanopowder (Sm2O3, 99.9%, 42-55 nm) | 4950YS | 咨询 |
| Samarium Oxide Nanopowder (Sm2O3, 99.9%, 15-30 nm) | 4951RE | 咨询 |
| Titanium Oxide Nanopowder (TiO2, amorphous/anatase, 99+%, 5 nm) | 5416HT | 咨询 |
| Titanium Oxide Nanopowder (TiO2, anatase, 99%, 10-30 nm) | 5420HT | 咨询 |
| Titanium Oxide Nanopowder(TiO2, anatase, 99%,15 nm) | 5430MR | 咨询 |
| Titanium Oxide Nanopowder (TiO2, anatase, 99+%, 10 nm) | 5417HT | 咨询 |
| Titanium Oxide Nanopowder (tungsten oxide doped, TiO2/WO3, anatase, 10 nm) | 5418HT | 咨询 |
| Titanium Oxide Nanopowder (TiO2, anatase, 5 nm) | 5421ZH | 咨询 |
| Titanium Oxide Nanotubes (TiO2, anatase, 99%, 10-15 nm) | 5432HW | 咨询 |
| Titanium Oxide Nanopowder (TiO2, anatase/rutile, 99+%, 20 nm) | 5419HT | 咨询 |
| Titanium oxide, silica & alumina coated (anatase/rutile, 30 nm) | 5426HT | 咨询 |
| Titanium oxide (silica, alumina & stearic acid coated, anatase/rutile, 30 nm) | 5427HT | 咨询 |
| Titanium Oxide Nanopowder (silica, alumina & silicone oil coated, anatase/rutile, 30 nm) | 5428HT | 咨询 |
| Titanium oxide, silica coated (anatase/rutile, 20 nm) | 5422HT | 咨询 |
| Titanium oxide, silica & alumina coated (anatase/rutile, 20 nm) | 5423HT | 咨询 |
| Titanium oxide, silica & stearic acid coated (anatase/rutile, 20 nm) | 5424HT | 咨询 |
| Titanium oxide, silica & silicone oil coated (anatase/rutile, 20 nm) | 5425HT | 咨询 |
| Titanium Oxide Nanopowder (TiO2, rutile, 99.9+%, 500 nm) | 5429HT | 咨询 |
| Titanium Oxide Nanopowder (TiO2, rutile, 99.9+%, 150 nm) | 5430HT | 咨询 |
| Titanium Oxide Nanopowder (TiO2, rutile, 99.9+%, 100 nm) | 5431HT | 咨询 |
| Titanium Oxide Nanopowder (TiO2, rutile, 99.8%, 60 nm) | 5486WJ | 咨询 |
| Titanium Oxide Nanopowder (TiO2, rutile, 99.8%, 20-50 nm) | 5484WJ | 咨询 |
| Titanium Oxide (TiO2, rutile, coated with silicon oxide, 20 nm) | 0302HT | 咨询 |
| Titanium Oxide (TiO2, rutile, coated with silicon oxide, 20 nm) | 0301HT | 咨询 |
| Vanadium Oxide Nanopowder (VO2, 99.9+%, 100 - 200 nm) | 5495HW | 咨询 |
| 1.5% Tungsten-doped Vanadium Oxide Nanopowder (W-doped VO2, 99.9+%, 30 - 50 nm) | 5499HW | 咨询 |
| 1% Tungsten-doped Vanadium Oxide Nanopowder (W-doped VO2, 99.9+%, 30 - 50 nm) | 5498HW | 咨询 |
| Tungsten Oxide Nanopowder (WO3, 99.5%, 60-120 nm) | 5508YL | 咨询 |
| Tungsten Oxide Nanopowder (WO3, 99.9+%, 40-50 nm) | 5506BD | 咨询 |
| Tungsten Oxide Nanopowder (WO3, 99+%, 30-70 nm) | 5505YL | 咨询 |
| Tungsten Oxide Nanopowder (WO3, 99+%, 30-70 nm, PVP-coated) | 5506YL | 咨询 |
| Yttrium Oxide Nanopowder (Y2O3, 99.995%, 50-70 nm) | 5610ZQ | 咨询 |
| Yttrium Oxide Nanopowder (Y2O3, 99.99%, 20-40 nm) | 5611RE | 咨询 |
| Yttrium Oxide Nanopowder (Y2O3, 99.9%, 32-36 nm) | 5650YS | 咨询 |
| Yttrium Oxide Nanopowder (Y2O3, 99.995%, 20-40 nm) | 5611ZQ | 咨询 |
| Ytterbium Oxide Nanopowder (Yb2O3, 10-80 nm, 99.9%) | 5671RE | 咨询 |
| Zinc Oxide Nanopowder (ZnO, 99+%, 800 nm) | 5816HT | 咨询 |
| Zinc Oxide Nanopowder (ZnO, 99%, 30 nm) | 5811HT | 咨询 |
| Zinc Oxide Nanopowder (ZnO, 98+%, 30 nm, hydrophilic & lipophilic) | 5812HT | 咨询 |
| Zinc Oxide Nanopowder (ZnO, 98+%, 30 nm, silicone oil coated) | 5814HT | 咨询 |
| Zinc Oxide Nanopowder (ZnO, 98+%, 30 nm, stearic acid coated) | 5815HT | 咨询 |
| Zinc Oxide Nanopowder (ZnO, 99%, 20 nm) | 5810HT | 咨询 |
| Zirconium Oxide Nanopowder (ZrO2, 99+%, 50 nm) | 5936HT | 咨询 |
| Zirconium Oxide Nanopowder (ZrO2, 99.5+%, 20 nm) | 5931HT | 咨询 |
| Zirconia Nanopowder, Yttria Doped (ZrO2/3 mol% Y2O3, 99.5+%, 15-50 nm) | 5932HT | 咨询 |
| Zirconia Nanopowder, Yttria Doped (ZrO2/5 mol% Y2O3, 99.5+%, 15-50 nm) | 5934HT | 咨询 |
| Zirconia Nanopowder, Yttria Doped (ZrO2/8 mol% Y2O3, 99.5+%, 15-50 nm) | 5933HT | 咨询 |
| Zirconia Nanopowder, Calcia Doped (ZrO2/8 mol%CaO, 99.9%, 20-30 nm) | 5934ZS | 咨询 |
| Barium Titanate Nanopowder (BaTiO3 , 99.9%, 400 nm) | 1146DY | 100g; |
| Barium Titanate Nanopowder (BaTiO3 , 99.9%, 300 nm) | 1144DY | 咨询 |
| Barium Titanate Nanopowder (BaTiO3 , 99.5%, 100-200 nm) | 1148DY | 咨询 |
| Cobalt Iron Oxides Nanopowder (CoFe2O4, 98%, 35-55 nm) | 1510FY | 25g ; 100g; |
| Cobalt-Zinc Iron Oxide Nanopowder (Co0.5Zn0.5Fe2O4, 99.5%, 30-50 nm) | 1515FY | 25g ; 100g; |
| Indium Tin Oxide Nanopowder (In2O3:SnO2 = 90wt%:10wt%, 99.99%, 20-70 nm) | 2730TN | 5g; 25g; |
| Indium Tin Oxide Nanopowder (In2O3:SnO2 = 95 wt%:5 wt%, 99.99%, 30-50 nm) | 2731BY | 5g; 25g; |
| Nickel-Zinc Iron Oxide Nanopowder (Ni0.5Zn0.5Fe2O4, 98.5%, 10-30 nm) | 4115FY | 100g; 500g; |
| *Ni80Fe17Mo3 permalloy nanopowder (99+%, 70 nm) | 9288HW | 100g; |
| Yttrium Aluminate w/Nd doped (Y2.98Nd0.02Al5O12, Nd-YAG, 99.5%, 40 nm) | 5571FY | 25g; 100g; |
| Zinc Iron Oxide Nanopowder (ZnFe2O4, 98.5%, 40 nm) | 5710FY | 100g; |
更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com

美国Neuro Probe公司专业提供用于趋化实验的耗材(Transwell),更好地服务于药筛和基础实验研究领域。着重开发研究细胞活性实验相关的耗材,从第一代用于趋化实验的Boyden Chamer(单孔小室)到48微孔板的趋化小室,再到今天的ChemTx System他们始终与科学实验的步伐保持一致,追求创新,不断地开发新产品以满足多样化的实验需求。
Neuro Probe was founded in the late 1960’s with an initial focus on the development and manufacture of chronic stereotactic equipment. In the early 1970’s, corporate growth and diversification lead to the development and production of chemotactic instruments, beginning with the modified Boyden chamber and then assorted blind well chambers. In 1980, the 48-well microchemotaxis chamber was developed, in collaboration with Dr. Edward Leonard and Dr. Werner Falk working at the National Institutes of Health. This chamber has become a standard in the field and has served as a basis for the development of many new products. Most recently introduced is the ChemoTx® system. Please visit the Products section of our website for more information on specific products.
Neuroprobe的主要产品包括:
ChemoTx®
Chemotaxis Chambers
Single Well Chambers
Filters
Replacement Gaskets
Chemotaxis Accessories
Protein Crystallography
Cell Settling Chambers
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com

LI-COR Biosciences分为三大业务板块:环境科学产品、生物技术产品、临床试验产品。
LI-COR technology enables scientists around the world to improve lives by advancing discovery. From the first low-cost light sensor filtered for the waveband absorbed by plants, to pioneering the development of near-infrared fluorescence detection systems for DNA sequencing, LI-COR strives to provide innovative solutions for researchers.
Today, LI-COR Biosciences is a leading innovator in systems for plant research, gas analysis, drug discovery, protein research, and small animal imaging.
LI-COR Biosciences的主要产品包括:
(1)Environmental Product Line
Eddy Covariance (CH4 " data-original="http://plant.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="LI-COR Biosciences">
LI-COR Biosciences
RNAssist专注于单细胞分析中生物大分子的稳定剂研发,其专利性的产品在保障RNA和生物分子稳定性的同时,还可以有效保存细胞形态,和使病毒/细菌失活。三个系列的产品,包括vivoPHIX™, genoPHIX™和virusPHIX™,他们都能够对临床样本提供有效保护和灭活病原体,同时各自又有不同的功效,适用于细胞&组织固定、ISH、IF、scRNA-seq、二代测序等领域。
<【vivoPHIX】
vivoPHIX™ 单细胞组学专用组织RNA稳定剂,10ml
vivoPHIX™ (10ml) – RNA stabilisation solution for single cell analysis
货号:RD-VIVO-10
<vivoPHIX™ 单细胞组学专用组织RNA稳定剂,20ml
vivoPHIX™ (20ml) – RNA stabilisation solution for single cell analysis
货号:RD-VIVO-20
<vivoPHIX™ 单细胞组学专用组织RNA稳定剂,30ml
vivoPHIX™ (30ml) – RNA stabilisation solution for single cell analysis
货号:RD-VIVO-30
<vivoPHIX™ 单细胞组学专用组织RNA稳定剂,50ml
vivoPHIX™ (50ml) – RNA stabilisation solution for single cell analysis
货号:RD-VIVO-50
vivoPHIX™单细胞组学专用组织RNA稳定剂,可以用于组织中RNA的固定保存,特别适合后续多组学检测,包括scRNA-seq试验和SMART-seq试验。其发挥的作用包括:生物分子的稳定(RNA、DNA和磷酸化蛋白)、细胞固定、组织分离和病毒/细菌灭活。
<【genoPHIX】
genoPHIX™ 全组分组织稳定剂,20ml
genoPHIX™ 20ml: For projects involving large tissue samples
货号:RD-GENO-20
<genoPHIX™ 全组分组织稳定剂,50ml
genoPHIX™ 50ml: For projects involving large tissue samples
货号:RD-GENO-50
genoPHIX™ 全组分组织稳定剂,适合应用于石蜡包埋组织样品。其独特的性质,使得这个试剂可以从石蜡包埋组织中提取核酸并保持其稳定性,是IHC、IF、FISH、荧光蛋白检测的理想选择。
【virusPHIX】
<virusPHIX™ – RNA Stabiliser and virus inactivation reagent
virusPHIX™ RNA稳定及病毒灭活试剂
货号:N/A
(1)稳定组织样品中的RNA、DNA和磷酸化蛋白;
(2)对组织样品中病毒、细菌、酵母进行有效灭活,提高生物安全性;
(3)适合分子测试;
(4)可与多种RNA提取试剂盒配合使用,包括:RNeasy™, QIAamp™, QIAsymphony™, QIAcube™, Nuclisens™, GeneXpert™and Filmarray™
(5)无毒、稳定、常温运输。
< " data-original="http://plant.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="RNAssist系列稳定剂(virusPHIX™、genoPHIX™、vivoPHIX™)"> RNAssist系列稳定剂(virusPHIX™、genoPHIX™、vivoPHIX™)
Anogen-Yes Biotech Laboratories Ltd. 创建于1989年, 位于加拿大多伦多近郊的著名高科技城市密西沙加市。Anogen是加拿大逸士生物技术研究有限公司在国际上的市场经销部门。Anogen-Yes Biotech Laboratories Ltd.研发和生产各种新颖抗体及有关产品,应用广泛的技术平台设计和开发各种单克隆抗体、多克隆抗体、基因工程/人源化抗体、免疫检验用配对抗体、免疫球蛋白、活性多肽、酶联免疫试剂盒[ELISA]、斑点酶联免疫试剂盒[Elispots]和基因重组蛋白质等等。 这些产品主要用于生命科学研究和各种疾病的诊断和防治,包括炎症和自身免疫性疾病、心血管病和癌症等。
Anogen is the trade name of Yes Biotech Laboratories Ltd., a Canadian biopharmaceutical company based in Mississauga, Ontario. Founded in 1989, Anogen-Yes Biotech specializes in developing and manufacturing monoclonal antibodies, recombinant proteins, synthetic bioactive peptides, and Enzyme linked immunosorbent assay (ELISA) kits for research as well as diagnostic and therapeutic use.[1] It is also committed to seeking medical treatment of cancer, autoimmune, inflammatory and cardiovascular diseases by developing antibody-based biopharmaceuticals.
Anogen的主要产品包括:
Monoclonal Antibodies
Polyclonal Antibodies
Matched Antibody Pairs
ELISA Kits
按照研究领域细分:
Inflammatory & Growth Factors
Cell Biology & Molecular Biology
Immunoassay Reagents
Infection & Toxin
Coagulation Factors
Hormone
Neurological Disorder
Tumor Research
| 品名 | 货号 | 规格 |
| mAb anti-Human TNF-α, CH8810 | MO-C40003A | 0.1 mg |
| mAb anti-Human TNF-α, CH8820, Capture | MO-C40003B | 0.1 mg |
| mAb anti-Human TNF-α, C2H9 | MO-C40003D | 0.1 mg |
| mAb anti-Human TNF-α, B1E4, Detector | MO-C40003E | 0.1 mg |
| mAb anti-Human TNF-α, C2A7 | MO-C40003F | 0.1 mg |
| mAb anti-Human TNF-α, C5G7 | MO-C40003G | 0.1 mg |
| mAb anti-Human TNF-α, C4C7 | MO-C40003H | 0.1 mg |
| mAb anti-Human IFN-γ, 315 | MO-C40004D | 0.1 mg |
| mAb anti-Human IFN-γ, 165 | MO-C40004E | 0.1 mg |
| mAb anti-Human IFN-γ, 23 | MO-C40004F | 0.1 mg |
| mAb anti-Human CCR1, 293 | MO-C40005A | 0.1 mg |
| mAb anti-Human TGF-β, TB21 | MO-C40009A | 0.1 mg |
| mAb anti-Human TGF-β, 2C5 | MO-C40009B | 0.1 mg |
| mAb anti-Human TGF-β, 2C6 | MO-C40009D | 0.1 mg |
| mAb anti-Human TGF-β, 2E6 | MO-C40009E | 0.1 mg |
| mAb anti-Human TGF-β, 8C4 | MO-C40009F | 0.1 mg |
| mAb anti-Human IL-8, I8-S2, Capture | MO-C40017A | 0.1 mg |
| mAb anti-Human IL-8, I8-60, Detector | MO-C40017D | 0.1 mg |
| mAb anti-Human IL-8, I8-61 | MO-C40017E | 0.1 mg |
| mAb anti-Human IL-8, 257 | MO-C40017F | 0.1 mg |
| mAb anti-Human IL-8, 807 | MO-C40017G | 0.1 mg |
| mAb anti-Human MCP-1, S8 | MO-C40021A | 0.1 mg |
| mAb anti-Human MCP-1, S14, Capture | MO-C40021B | 0.1 mg |
| mAb anti-Human MCP-1, S101, Detector | MO-C40021D | 0.1 mg |
| mAb anti-Human MCP-1, 9G10 | MO-C40021E | 0.1 mg |
| mAb anti-Human MCP-1, S382 | MO-C40021F | 0.1 mg |
| mAb anti-Human SAA, 115, Capture | MO-C40028A | 0.1 mg |
| mAb anti-Human SAA, 513 | MO-C40028D | 0.1 mg |
| mAb anti-Human SAA, 607, Detector | MO-C40028E | 0.1 mg |
| mAb anti-Human SAA, 291 | MO-C40028G | 0.1 mg |
| mAb anti-Human SAA, 504 | MO-C40028H | 0.1 mg |
| mAb anti-Human SAA, 585 | MO-C40028J | 0.1 mg |
| mAb anti-Human SAA, 426 | MO-C40028K | 0.1 mg |
| mAb anti-Human SAA, 38 | MO-C40028L | 0.1 mg |
| mAb anti-Human SAA, 132 | MO-C40028M | 0.1 mg |
| mAb anti-Human SAA, S3 | MO-C40028N | 0.1 mg |
| mAb anti-Human IL-1β, S1H12 | MO-C40029A | 0.1 mg |
| mAb anti-Human IL-1β, S1B7 | MO-C40029B | 0.1 mg |
| mAb anti-Human IL-1β, S3F12 | MO-C40029G | 0.1 mg |
| mAb anti-Human IL-1β, 464 | MO-C40029H | 0.1 mg |
| mAb anti-Human IL-2, 5A8, | MO-C40032A | 0.1 mg |
| mAb anti-Human IL-2, 9F9, | MO-C40032B | 0.1 mg |
| mAb anti-Human IL-2, 10C4 | MO-C40032C | 0.1 mg |
| mAb anti-Human IL-2, 8C2 | MO-C40032D | 0.1 mg |
| mAb anti-Human IL-2, 6F11 | MO-C40032E | 0.1 mg |
| mAb anti-Human IL-2, 6B1 | MO-C40032F | 0.1 mg |
| mAb anti-Human EGF, S-21 | MO-C40044A | 0.1 mg |
| mAb anti-Human EGF, S-120 | MO-C40044B | 0.1 mg |
| mAb anti-Human EGF, S-134, Capture | MO-C40044D | 0.1 mg |
| mAb anti-Human EGF, S-145 | MO-C40044E | 0.1 mg |
| mAb anti-Human EGF, S-146, Detector | MO-C40044F | 0.1 mg |
| mAb anti-Human EGF, S-147 | MO-C40044G | 0.1 mg |
| mAb anti-Human EGF, S-177 | MO-C40044H | 0.1 mg |
| mAb anti-Human G-CSFR, S-1252 | MO-C40045A | 0.1 mg |
| mAb anti-Human G-CSFR, S-1268 | MO-C40045B | 0.1 mg |
| mAb anti-Human G-CSFR, S-1284 | MO-C40045D | 0.1 mg |
| mAb anti-Human G-CSFR, S-1374 | MO-C40045E | 0.1 mg |
| mAb anti-Human G-CSFR, S-425 | MO-C40045F | 0.1 mg |
| mAb anti-Human G-CSFR, S-1390 | MO-C40045G | 0.1 mg |
| mAb anti-Human bFGF, F-343 | MO-C40046A | 0.1 mg |
| mAb anti-Human bFGF, F-74 | MO-C40046B | 0.1 mg |
| mAb anti-Human bFGF, F-474 | MO-C40046F | 0.1 mg |
| mAb anti-Human bFGF, F-3 | MO-C40046H | 0.1 mg |
| mAb anti-Human EPO, 85 | MO-C40047A | 0.1 mg |
| mAb anti-Human M-CSF, 116 | MO-C40048A | 0.1 mg |
| mAb anti-Human M-CSF, 692 | MO-C40048B | 0.1 mg |
| mAb anti-Human M-CSF, 21 | MO-C40048D | 0.1 mg |
| mAb anti-Human MIP-1α, 116 | MO-C40051A | 0.1 mg |
| mAb anti-Human MIP-1α, 125 | MO-C40051D | 0.1 mg |
| mAb anti-Human MIP-1α, 548 | MO-C40051F | 0.1 mg |
| mAb anti-Human MIP-1α, 199 | MO-C40051G | 0.1 mg |
| mAb anti-Human MIP-1α, 400 | MO-C40051L | 0.1 mg |
| mAb anti-Human MIP-1α, 103 | MO-C40051M | 0.1 mg |
| mAb anti-Human MIP-1α, 376 | MO-C40051N | 0.1 mg |
| mAb anti-Human MIP-1α, 426 | MO-C40051P | 0.1 mg |
| mAb anti-Human MCP-3, 113, Detector | MO-C40088A | 0.1 mg |
| mAb anti-Human MCP-3, 343 | MO-C40088B | 0.1 mg |
| mAb anti-Human MCP-3, 490 | MO-C40088D | 0.1 mg |
| mAb anti-Human MCP-3, 768 | MO-C40088E | 0.1 mg |
| mAb anti-Human MCP-3, 1057 | MO-C40088F | 0.1 mg |
| mAb anti-Human MCP-3, 542, Capture | MO-C40088G | 0.1 mg |
| mAb anti-Human MCP-3, 1015 | MO-C40088H | 0.1 mg |
| mAb anti-Human IL-16, 59 | MO-C40089G | 0.1 mg |
| mAb anti-Human IL-16, 210 | MO-C40089H | 0.1 mg |
| mAb anti-Human IL-16, 323, Detector | MO-C40089J | 0.1 mg |
| mAb anti-Human IL-16, 398, Capture | MO-C40089K | 0.1 mg |
| mAb anti-Human IL-16, 568 | MO-C40089M | 0.1 mg |
| mAb anti-Human IL-16, 572 | MO-C40089N | 0.1 mg |
| mAb anti-Human GM-CSF, 29 | MO-C40090A | 0.1 mg |
| mAb anti-Human GM-CSF, 59, Capture | MO-C40090B | 0.1 mg |
| mAb anti-Human GM-CSF, 429, Detector | MO-C40090D | 0.1 mg |
| mAb anti-Human GM-CSF, 204 | MO-C40090E | 0.1 mg |
| mAb anti-Human GM-CSF, 489 | MO-C40090F | 0.1 mg |
| mAb anti-Human GM-CSF, 120 | MO-C40090G | 0.1 mg |
| mAb anti-Human GM-CSF, 26 | MO-C40090H | 0.1 mg |
| mAb anti-Human GM-CSF, 174 | MO-C40090K | 0.1 mg |
| mAb anti-Human GM-CSF, S333 | MO-C40090L | 0.1 mg |
| mAb anti-Human IL-6, 2E10 | MO-C40091B | 0.1 mg |
| mAb anti-Human IL-6, 8E10 | MO-C40091C | 0.1 mg |
| mAb anti-Human IL-6, 5G8 | MO-C40091D | 0.1 mg |
| mAb anti-Human IL-6, 1B6 | MO-C40091E | 0.1 mg |
| mAb anti-Human IL-6, 1E3 | MO-C40091F | 0.1 mg |
| mAb anti-Human IL-6, 6D7 | MO-C40091G | 0.1 mg |
| mAb anti-Human IL-6, 9D8 | MO-C40091H | 0.1 mg |
| mAb anti-Human IL-10, 4H2 | MO-C40092A | 0.1 mg |
| mAb anti-Human IL-10, 6D2 | MO-C40092B | 0.1 mg |
| mAb anti Human IL-17A clone 4C1, Capture | MO-C40093A | 0.1mg |
| mAb anti Human IL-17A clone 2F3 | MO-C40093B | 0.1mg |
| mAb anti Human IL-17A clone 8H7 | MO-C40093C | 0.1mg |
| mAb anti Human IL-17A clone 5B4 | MO-C40093D | 0.1mg |
| mAb anti Human IL-17A clone 1E2 | MO-C40093E | 0.1mg |
| mAb anti Human IL-17A clone 2D11 | MO-C40093H | 0.1mg |
| mAb anti Human IL-17A clone 3C1 | MO-C40093I | 0.1mg |
| mAb anti Human IL-17A clone 3H11, Detector | MO-C40093K | 0.1mg |
| mAb anti Human IL-17A clone 5A9 | MO-C40093M | 0.1mg |
| mAb anti Human IL-17A clone 6F12 | MO-C40093O | 0.1mg |
| mAb anti Human IL-17A clone 7F10 | MO-C40093S | 0.1mg |
| mAb anti Human IL-17A clone 10F9 | MO-C40093W | 0.1mg |
| mAb anti Human IL-18 clone 2A10, Capture | MO-C40094A | 0.1mg |
| mAb anti Human IL-18 clone 10H4, Detector | MO-C40094B | 0.1mg |
| mAb anti human IL-18 clone 10H4, Tracer (Biotin Labeled) | MO-C40094TB | 0.1 mL |
| mAb anti Human IL-15 clone 5E8, Capture | MO-C40095A | 0.1mg |
| mAb anti Human IL-15 clone B1H6, Detector | MO-C40095B | 0.1mg |
| mAb anti-human LIF, Clone 2C6 | MO-C40096A | 0.1mg |
| mAb anti-human LIF, Clone 3F4 | MO-C40096B | 0.1mg |
| mAb anti-human LIF, Clone 8B10 | MO-C40096C | 0.1mg |
| mAb anti-DYKDDDDK (Flag) Tag, Flag.10F4 | MO-H40001B | 0.1 mg |
| mAb anti-GAPDH, H8 | MO-H40002A | 0.1 mg |
| mAb anti-HA Tag, HA52 | MO-H40004A | 0.1 mg |
| mAb anti-His Tag, 10A12 | MO-H40005B | 0.1 mg |
| mAb anti-Myc Tag, MycA7 | MO-H40006A | 0.1 mg |
| mAb anti-V5 Tag, V531 | MO-H40007A | 0.1 mg |
| mAb anti-HIV-1 P24 (Core Protein), 473, Detector | MO-I40002A | 0.1 mg |
| mAb anti-HIV-1 P24 (Core Protein), 163 | MO-I40002C | 0.1 mg |
| mAb anti-HIV-1 P24 (Core Protein), 340, Capture | MO-I40002D2 | 0.1 mg |
| mAb anti-HIV-1 P24 (Core Protein), 587, 0.1 mg | MO-I40002E | 0.1 mg |
| mAb anti-HIV-1 P24 (Core Protein), 425 | MO-I40002I | 0.1 mg |
| mAb anti-HIV-1 P24 (Core Protein), 1027 | MO-I40002J | 0.1 mg |
| mAb anti-HIV-1 P24 (Core Protein), 287 | MO-I40002N | 0.1 mg |
| mAb anti-HIV-1 P24 (Core Protein), 161 | MO-I40002P | 0.1 mg |
| mAb anti-HBsAg, RM-1 | MO-I40013A | 0.1 mg |
| mAb anti-HCV Core Protein, A1/3D1 | MO-I40015A | 0.1 mg |
| mAb anti-HCV Core Protein, B2 | MO-I40015B | 0.1 mg |
| mAb anti-HCV Core Protein, C3 | MO-I40015E | 0.1 mg |
| mAb anti-HCV NS-4, 7B7/5G9 | MO-I40016B | 0.1 mg |
| mAb anti-HCV NS-4, 5D4/10E7 | MO-I40016D | 0.1 mg |
| mAb anti-HCV NS-4, 7E11 | MO-I40016F | 0.1 mg |
| mAb anti-HCV NS-4, 202 | MO-I40016J | 0.1 mg |
| mAb anti-HCV NS-4, 101 | MO-I40016K | 0.1 mg |
| mAb anti-HCV NS-4, 174 | MO-I40016L | 0.1 mg |
| mAb anti-HCV NS-4, 497 | MO-I40016M | 0.1 mg |
| mAb anti-HCV NS-3, 70-13 | MO-I40018A | 0.1 mg |
| mAb anti-HCV NS-3, 1-5 | MO-I40018B | 0.1 mg |
| mAb anti-HCV NS-3, 12-15 | MO-I40018D | 0.1 mg |
| mAb anti-HCV NS-3, 5-11 | MO-I40018E | 0.1 mg |
| mAb anti-HCV NS-3, 24-8 | MO-I40018F | 0.1 mg |
| mAb anti-HCV NS-3, 20-8 | MO-I40018G | 0.1 mg |
| mAb anti-HCV NS-3, 113 | MO-I40018H | 0.1 mg |
| mAb anti-HCV NS-3, 281 | MO-I40018J | 0.1 mg |
| mAb anti-HCV NS-3, 806 | MO-I40018K | 0.1 mg |
| mAb anti-HCV NS-3, 5 | MO-I40018L | 0.1 mg |
| mAb anti-HCV NS-3, 328 | MO-I40018M | 0.1 mg |
| mAb anti-HCV NS-3, 251 | MO-I40018N | 0.1 mg |
| mAb anti-HCV NS-3, 242 | MO-I40018P | 0.1 mg |
| mAb anti-HCV NS-3, 133 | MO-I40018Q | 0.1 mg |
| mAb anti-HEV, S-13 | MO-I40019B | 0.1 mg |
| mAb anti-HEV, 4H5 | MO-I40019C | 0.1 mg |
| mAb anti-HEV, 2H6 | MO-I40019D | 0.1 mg |
| mAb anti-HEV, 2H2 | MO-I40019E | 0.1 mg |
| mAb anti-HEV, 1B6 | MO-I40019F | 0.1 mg |
| mAb anti-HEV, 5H4 | MO-I40019G | 0.1 mg |
| mAb anti-HP CagA, 10E9, | MO-I40020A | 0.1 mg |
| mAb anti-HP CagA, 5H10 | MO-I40020B | 0.1 mg |
| mAb anti-HP CagA, 5C6 | MO-I40020C | 0.1 mg |
| mAb anti-HP CagA, 3C10, | MO-I40020D | 0.1 mg |
| mAb anti-HP CagA, 3C1 | MO-I40020E | 0.1 mg |
| mAb anti-TB 38KD Antigen, D2G2 | MO-I40021A | 0.1 mg |
| mAb anti-TB 38KD Antigen, C12H11 | MO-I40021B | 0.1 mg |
| mAb anti-TB 38KD Antigen, C11B10 | MO-I40021C | 0.1 mg |
| mAb anti-TB 38KD Antigen, B12F8 | MO-I40021D | 0.1 mg |
| mAb anti-TB 38KD Antigen, A11D2 | MO-I40021E | 0.1 mg |
| mAb anti-TB 38KD Antigen, A2H8 | MO-I40021F | 0.1 mg |
| mAb anti-Human CD3, JXT3 | MO-L40001A | 0.1 mg |
| Rat anti-Mouse CD4, JXYT4 | MO-L40026 | 0.1 mg |
| Rat anti-Mouse CD8, JXYT8 | MO-L40027 | 0.1 mg |
| mAb anti-Human CD11α, A11 | MO-L40028 | 0.1 mg |
| mAb anti-Human HLA-ABC, LY5.1 | MO-L40033 | 0.1 mg |
| mAb anti-Human CD71 Transferrin Receptor, CY-TFR | MO-L40042 | 0.1 mg |
| mAb anti-Human PD-1 / CD279, 1C4 | MO-L40043A | 0.1 mg |
| mAb anti-Human PD-1 / CD279, 7C9, Capture | MO-L40043B | 0.1 mg |
| mAb anti-Human PD-1 / CD279, 9E11 | MO-L40043E | 0.1 mg |
| mAb anti-Human PD-1 / CD279, 9B4 | MO-L40043F | 0.1 mg |
| mAb anti-Human PD-1 / CD279, B1C4 | MO-L40043G | 0.1 mg |
| mAb anti-Human PD-1 / CD279, 7G12, Detector | MO-L40043L | 0.1 mg |
| mAb anti-Human PD-1 / CD279, 2H7 | MO-L40043M | 0.1 mg |
| mAb anti Human PD-L1, clone 6A5 | MO-L40044E | 0.1 mg |
| mAb anti Human PD-L1 clone 8C12 | MO-L40044F | 0.1 mg |
| mAb anti Human PD-L1 clone 12B4, Detector | MO-L40044I | 0.1 mg |
| mAb anti Human PD-L1 clone 11D11 | MO-L40044M | 0.1 mg |
| mAb anti Human PD-L1 clone 15G3, Capture | MO-L40044N | 0.1 mg |
| mAb anti Human PD-L1 clone 12D9 | MO-L40044O | 0.1 mg |
| mAb anti Human PD-L1 clone 15F2 | MO-L40044R | 0.1 mg |
| mAb anti Human PD-L1, clone 10B12 | MO-L40044S | 0.1 mg |
| mAb anti Human CD47, clone 1G10 | MO-L40045A | 0.1 mg |
| mAb anti Human CD47, clone 8H7 | MO-L40045B | 0.1 mg |
| mAb anti Human CD47, clone 9F10 | MO-L40045C | 0.1 mg |
| mAb anti Human CD44, clone 2G7 | MO-L40046A | 0.1 mg |
| mAb anti Human CD44, clone 3C7 | MO-L40046B | 0.1 mg |
| mAb anti-hCG-α, CH5 | MO-M40010A | 0.1 mg |
| mAb anti-hCG-α, CH7 | MO-M40010B | 0.1 mg |
| mAb anti-TRICHOSANTHIN (TCST), TCST-1, 0.1 mg | MO-M40011A | 0.1 mg |
| mAb anti-hGH, YC6, Capture | MO-M40012A | 0.1 mg |
| mAb anti-Human Ig Kappa Light Chain, YCK1 | MO-M40020 | 0.1 mg |
| mAb anti-Human B2MG, D6E4 | MO-M40021B | 0.1 mg |
| mAb anti-Human B2MG, D2E9, Capture | MO-M40021C | 0.1 mg |
| mAb anti-Human B2MG, D6D1 | MO-M40021D | 0.1 mg |
| mAb anti-Human B2MG, D2A10 | MO-M40021E | 0.1 mg |
| mAb anti-Human B2MG, D3A2, Detector | MO-M40021F | 0.1 mg |
| mAb anti-human CRP, 63F4, Capture | MO-M40023A | 0.1 mg |
| mAb anti-human CRP, 67A1 | MO-M40023B | 0.1 mg |
| mAb anti-human CRP, N1G1 | MO-M40023D | 0.1 mg |
| mAb anti-human CRP, S5G1 | MO-M40023E | 0.1 mg |
| mAb Rat anti-Aflatoxin, 1C6, 0.1 mg | MO-M40025A | 0.1 mg |
| mAb Rat anti-Aflatoxin, 1E6, 0.1 mg | MO-M40025B | 0.1 mg |
| mAb Rat anti-Aflatoxin, 2E4 | MO-M40025D | 0.1 mg |
| mAb anti-Human Albumin, S4D6 | MO-M40036 | 0.1 mg |
| mAb anti-Human Factor IX, F9-1, .01 mg | MO-M40037 | 0.1 mg |
| mAb anti-Human Protein C, HLW-C, 0.1 mg | MO-M40038 | 0.1 mg |
| mAb anti-Human Factor X, F10-1, 0.1 mg | MO-M40039 | 0.1 mg |
| mAb anti-Human GP IIb/IIIa, 237, 0.1 mg | MO-M40040A | 0.1 mg |
| mAb anti-Human GP IIb/IIIa, 474, 0.1 mg | MO-M40040B | 0.1 mg |
| mAb anti-Human GP IIb/IIIa, Y8 | MO-M40040D | 0.1 mg |
| mAb anti-Human GP IIb/IIIa, 700 | MO-M40040E | 0.1 mg |
| mAb anti-Human GP IIb/IIIa, 585 | MO-M40040F | 0.1 mg |
| mAb anti-Human GP IIb/IIIa, 8 | MO-M40040H | 0.1 mg |
| mAb anti-Human GP IIb/IIIa, 291 | MO-M40040J | 0.1 mg |
| mAb anti-Human GP IIb/IIIa, 262 | MO-M40040N | 0.1 mg |
| mAb anti-Human GP IIb/IIIa, 71 | MO-M40040Q | 0.1 mg |
| mAb anti-Human GP IIb/IIIa, 128 | MO-M40040S | 0.1 mg |
| mAb anti-Staphylococcal Enterotoxin B [SEB], 0.1 mg | MO-M40041 | 0.1 mg |
| mAb anti-Human PTP1-C, PTY6 | MO-M40043A | 0.1 mg |
| mAb anti-Human PTP1-C, PTY11 | MO-M40043B | 0.1 mg |
| mAb anti-Human PTP1-C, PTY15 | MO-M40043D | 0.1 mg |
| mAb anti-Human PTP1-C, PTY10 | MO-M40043E | 0.1 mg |
| mAb anti-Human PTP1-C, PTY13 | MO-M40043F | 0.1 mg |
| mAb anti-human TSH, TSH-2, Detector | MO-M40046A | 0.1 mg |
| mAb anti-human TSH, TSH-1, Capture | MO-M40046B | 0.1 mg |
| mAb anti-Human Prolactin, PRL-1, Capture | MO-M40047B | 0.5 mg |
| mAb anti-Human LH, LH-1, Capture | MO-M40048B | 0.5 mg |
| mAb anti-hCG, HCG-1, Capture | MO-M40049B | 0.5 mg |
| mAb anti-Human FSH, FSH-1, Capture | MO-M40050B | 0.5 mg |
| mAb anti-Human Raf-1, 410 | MO-M40091E | 0.5 mg |
| mAb anti-Human Raf-1, 540 | MO-M40091G | 0.5 mg |
| mAb anti-Human Raf-1, 863 | MO-M40091J | 0.5 mg |
| mAb anti-Human Raf-1, 163 | MO-M40091M | 0.5 mg |
| mAb anti-Human NSE, 145 | MO-M40092A | 0.5 mg |
| mAb anti-Human NSE, 1G6 | MO-M40092B | 0.5 mg |
| mAb anti-Human NSE, 171 | MO-M40092C | 0.5 mg |
| mAb anti-Amyloid β Peptide 42, CA9 3B3 | MO-M40093A | 0.1 mg |
| mAb anti-Amyloid β Peptide 42, CA9 10C11, Detector | MO-M40093B | 0.5 mg |
| mAb anti-Amyloid β Peptide 42, CA9 3F8 | MO-M40093D | 0.5 mg |
| mAb anti-Amyloid β Peptide N-terminal, NT 3F5 | MO-M40094A | 0.5 mg |
| mAb anti-Amyloid β Peptide N-terminal, NT 1H3 | MO-M40094B | 0.5 mg |
| mAb anti-Amyloid β Peptide N-terminal, NT 6C8 | MO-M40094C | 0.5 mg |
| mAb anti-Amyloid β Peptide N-terminal, NT 5B8, Capture | MO-M40094D | 0.5 mg |
| mAb anti-Amyloid β Peptide N-terminal, NT 4A2 | MO-M40094E | 0.5 mg |
| mAb anti-Amyloid β Peptide N-terminal, NT 7H7 | MO-M40094F | 0.5 mg |
| mAb anti-Amyloid β Peptide N-terminal, NT 5A4 | MO-M40094G | 0.5 mg |
| mAb anti-Amyloid β Peptide N-terminal, NT 4B7 | MO-M40094H | 0.5 mg |
| mAb anti-Amyloid β Peptide N-terminal, NT 7G10 | MO-M40094I | 0.5 mg |
| mAb anti-Amyloid β Peptide N-terminal, NT 1F10 | MO-M40094J | 0.5 mg |
| mAb anti-Amyloid β Peptide 40, CV9 7B10, Detector | MO-M40095A | 0.1 mg |
| mAb anti-Amyloid β Peptide 40, CV9 8B2 | MO-M40095B | 0.1 mg |
| mAb anti-Amyloid β Peptide 40, 4B1 | MO-M40095C | 0.1 mg |
| mAb anti-Human α1-antitrypsin, 5G5 | MO-M40096A | 0.1 mg |
| mAb anti-Human α1-antitrypsin, 9F2 | MO-M40096B | 0.1 mg |
| mAb anti-Human α-Synuclein, 4H11 | MO-M40097A | 0.1 mg |
| mAb anti-Human α-Synuclein, 4C1 | MO-M40097B | 0.1 mg |
| mAb anti-Human α-Synuclein, 4B4 | MO-M40097C | 0.1 mg |
| mAb anti-Human α-Synuclein, 8F12 | MO-M40097D | 0.1 mg |
| mAb anti-Human α-Synuclein, 9A9 | MO-M40097E | 0.1 mg |
| mAb anti-Human α1-antichymotrypsin, 3E11 | MO-M40098A | 0.1 mg |
| mAb anti-Human α1-antichymotrypsin, B2B3 | MO-M40098B | 0.1 mg |
| mAb anti-Human α1-antichymotrypsin, B4H12 | MO-M40098C | 0.1 mg |
| mAb anti-Human α1-antichymotrypsin, B5B11 | MO-M40098D | 0.1 mg |
| mAb anti-Human α1-antichymotrypsin, B7B10 | MO-M40098E | 0.1 mg |
| mAb anti-Human α1-antichymotrypsin, B7H2 | MO-M40098F | 0.1 mg |
| mAb anti-Thr181 Phosphorylated Tau, 1A4 | MO-M40099A | 0.1 mg |
| mAb anti-Thr181 Phosphorylated Tau, 7G9 | MO-M40099B | 0.1 mg |
| mAb anti-Thr181 Phosphorylated Tau, 9B4 | MO-M40099C | 0.1 mg |
| mAb anti-Thr181 Phosphorylated Tau, 2A4 | MO-M40099D | 0.1 mg |
| mAb anti-human Thr212 Thr217 double phosphorylated Tau, 8E1 | MO-M40100A | 0.1 mg |
| mAb anti-human Thr212 Thr217 double phosphorylated Tau, 1G8 | MO-M40100B | 0.1 mg |
| mAb anti-human Thr212 Thr217 double phosphorylated Tau, 4C1 | MO-M40100C | 0.1 mg |
| mAb anti-human Thr212 Thr217 double phosphorylated Tau, 3B12 | MO-M40100D | 0.1 mg |
| mAb anti-human Thr212 Thr217 double phosphorylated Tau, 4H1 | MO-M40100E | 0.1 mg |
| mAb anti-human Thr212 Thr217 double phosphorylated Tau, 4H11 | MO-M40100F | 0.1 mg |
| mAb anti-human Thr212 Thr217 double phosphorylated Tau, 5C11 | MO-M40100G | 0.1 mg |
| mAb anti-human Thr212 Thr217 double phosphorylated Tau, 10G9 | MO-M40100H | 0.1 mg |
| mAb anti-LCRMP4, 5H5 | MO-M40101A | / |
| mAb anti-LCRMP4, 2H7 | MO-M40101B | / |
| mAb anti-LCRMP4 , 7E1 | MO-M40101C | / |
| mAb anti-Human Phospho-STAT5b [p-Y699], A4B9 | MO-P40001A | 0.1 mg |
| mAb anti-Human Phospho-STAT5b [p-Y699], A2H6 | MO-P40001B | 0.1 mg |
| mAb anti-Human Phospho-ELK-1 [p-S383], B4A12 | MO-P40002A | 0.1 mg |
| mAb anti-Human Phospho-ELK-1 [p-S383], D7H2 | MO-P40002B | 0.1 mg |
| mAb anti-Human Phospho-CREB [p-S133], A3A4 | MO-P40003A | 0.1 mg |
| mAb anti-Human Phospho-CREB [p-S133], B1C4 | MO-P40003B | 0.1 mg |
| mAb anti-Human FPRL-1 C-terminal, C4F9 | MO-P40006A | 0.1 mg |
| mAb anti-Human FPRL-1 C-terminal, B4D9B10 | MO-P40006B | 0.1 mg |
| mAb anti-Human FPRL-1 2nd extracellular loop, 3D7 | MO-P40007A | 0.1 mg |
| mAb anti-Human FPRL-1 2nd extracellular loop, B7H10 | MO-P40007B | 0.1 mg |
| mAb anti-Human Lung Carcinoma, CHALU2 | MO-T40005B | 0.1 mg |
| mAb anti-Human Lung Carcinoma, 3504 | MO-T40005C | 0.1 mg |
| mAb anti-Human Hepatocellular Carcinoma, CHALV1 | MO-T40006A | 0.1 mg |
| mAb anti-Human AFP, AFP-Y2, Detector | MO-T40007A | 0.1 mg |
| mAb anti-Human AFP, AFP-Y1, Capture | MO-T40007B | 0.1 mg |
| mAb anti-Human BPH, YBPH-1 | MO-T40008A | 0.1 mg |
| mAb anti-Human BPH, YBPH-2 | MO-T40008B | 0.1 mg |
| mAb anti-Human PML, B3E9 | MO-T40010A | 0.1 mg |
| mAb anti-Human PML, B4C8 | MO-T40010B | 0.1 mg |
| mAb anti-CA 125, 110 | MO-T40012A | 0.1 mg |
| mAb anti-CA 125, 76 | MO-T40012B | 0.1 mg |
| mAb anti-CA 125, 23 | MO-T40012C | 0.1 mg |
| mAb anti-CA 125, 15 | MO-T40012D | 0.1 mg |
| mAb anti-CA 125 | MO-T40012E | 0.1 mg |
| mAb anti-CA50, 93 | MO-T40014A | 0.1 mg |
| mAb anti-CA50, 826 | MO-T40014B | 0.1 mg |
| mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,8E2 (Free Sample Available) | MO-T40015A | 0.1 mg |
| mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,9B2 (Free Sample Available) | MO-T40015B | 0.1 mg |
| mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,1A5 (Free Sample Available) | MO-T40015C | 0.1 mg |
| mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,4E11 (Free Sample Available) | MO-T40015D | 0.1 mg |
| mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,9E1 (Free Sample Available) | MO-T40015E | 0.1 mg |
| mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,7C4 (Free Sample Available) | MO-T40015F | 0.1 mg |
| mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,7E6 (Free Sample Available) | MO-T40015G | 0.1 mg |
| mAb anti-Human Colorectal Carcinoma, Y94 | MO-T40022 | 0.1 mg |
| mAb anti-Human Colorectal Carcinoma/CD3, BS-1 | MO-T40035 | 0.1 mg |
| mAb anti-Human CEA, CEA-Y2, Detector | MO-T40051A | 0.1 mg |
| mAb anti-Human CEA, CEA-Y1, Capture | MO-T40051B | 0.1 mg |
| mAb anti-Human Free PSA, 103, Detector | MO-T40052A | 0.1 mg |
| mAb anti-Human Free PSA, 108, Capture | MO-T40052B | 0.1 mg |
| mAb anti-Human PSA, CHYH1, Capture | MO-T40081A | 0.1 mg |
| mAb anti-Human PSA, CHYH2, Dectector | MO-T40081B | 0.1 mg |
| mAb anti-Human PMA, YPMA-1 | MO-T40083A | 0.1 mg |
| mAb anti-Human PMA, YPMA-2 | MO-T40083B | 0.1 mg |
| mAb anti-Human PSP, YPSP-1 | MO-T40085A | 0.1 mg |
| mAb anti-Human PSP, YPSP-2 | MO-T40085B | 0.1 mg |
| mAb anti-Human PSP, YPSP-3 | MO-T40085C | 0.1 mg |
| mAb anti-Human PSP, YPSP-4 | MO-T40085D | 0.1 mg |
| mAb anti-Human PSMA, YPSMA-1 | MO-T40086A | 0.1 mg |
| mAb anti-Human PSMA, YPSMA-2 | MO-T40086B | 0.1 mg |
| mAb anti-Human PSMA, 4H11 | MO-T40086C | 0.1 mg |
| mAb anti-Human PSMA, 7F3 | MO-T40086D | 0.1 mg |
| mAb anti-Human PTMA, 8H12 | MO-T40087A | 0.1 mg |
| mAb anti-Human PTMA, 9A10 | MO-T40087B | 0.1 mg |
| mAb anti-Human PTMA, 6A3 | MO-T40087C | 0.1 mg |
| mAb anti-Human PTMA, 4G2 | MO-T40087D | 0.1 mg |
| mAb anti-Human PTMA, 5A10 | MO-T40087E | 0.1 mg |
| mAb anti-Human PTMA, 6H7 | MO-T40087F | 0.1 mg |
| mAb anti-Human PTMA, 1F2, Capture | MO-T40087G | 0.1 mg |
| mAb anti-Human PTMA, 4C3 | MO-T40087H | 0.1 mg |
| mAb anti-Human PTMA, 4A7, Detector | MO-T40087I | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 9A4 | MO-T40088A | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 2E6 | MO-T40088B | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 1A10 | MO-T40088C | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 5C2 | MO-T40088D | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 10H9 | MO-T40088E | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 2A3 | MO-T40088F | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 2E5 | MO-T40088G | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 5H12 | MO-T40088H | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 9C7 | MO-T40088I | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 9D5 | MO-T40088J | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 3E7 | MO-T40088K | 0.1 mg |
| Human PSA ELISA Kit | EL10005 | 96 wells |
| Human IL-8 ELISA Kit | EL10008 | 96 wells |
| Human MCAF / MCP-1 ELISA Kit | EL10009 | 96 wells |
| Human EGF ELISA Kit | EL10010 | 96 wells |
| Human LH ELISA Kit | EL10011 | 96 wells |
| Human TSH ELISA Kit | EL10012 | 96 wells |
| Neonatal TSH ELISA Kit | EL10012N | 96 wells |
| Ultra-Sensitive Human TSH ELISA Kit | EL10012U | 96 wells |
| Human FSH ELISA Kit | EL10013 | 96 wells |
| Human Prolactin ELISA Kit | EL10014 | 96 wells |
| Human SAA ELISA Kit | EL10015 | 96 wells |
| Human SAA ELISA Kit (2nd Generation) | EL10015L | 96 wells |
| Human MCP-3 ELISA Kit | EL10016 | 96 wells |
| Human TNF-α ELISA Kit | EL10019 | 96 wells |
| Human GM-CSF ELISA Kit | EL10020 | 96 wells |
| Human IL-16 ELISA Kit | EL10021 | 96 wells |
| High Sensitivity Human CRP ELISA Kit | EL10022hs | 96 wells |
| Human IL-6 ELISA Kit | EL10023 | 96 wells |
| Human IFN-γ ELISA Kit | EL10024 | 96 wells |
| Human IL-2 ELISA Kit | EL10025 | 96 wells |
| Human IL-4 ELISA Kit | EL10026 | 96 wells |
| Human IL-10 ELISA Kit | EL10027 | 96 wells |
| Human IL-1β ELISA Kit | EL10028 | 96 wells |
| Human TGF-β1 ELISA Kit | EL10029 | 96 wells |
| Human Growth Hormone (hGH) ELISA Kit/Hormone Elisa | EL10030 | 96 wells |
| High Sensitivity Human Growth Hormone (H-hGH) ELISA Kit | EL10030H | 96 wells |
| Human Chorionic Gonadotropin (hCG) ELISA Kit | EL10031 | 96 wells |
| Human IL-12 (P70) ELISA Kit | EL10032 | 96 wells |
| Human IL-2 sRα ELISA Kit | EL10033 | 96 wells |
| Human IL-6 sR ELISA Kit | EL10034 | 96 wells |
| Human IL-5 ELISA Kit | EL10035 | 96 wells |
| HAMA ELISA Kit | EL10036 | 96 wells |
| Human IL-13 Rα2 ELISA Kit | EL10039 | 96 wells |
| Human IL-1α ELISA Kit | EL10040 | 96 wells |
| Human IL-7 ELISA Kit | EL10041 | 96 wells |
| Human IL-11 ELISA Kit | EL10042 | 96 wells |
| Human IL-15 ELISA Kit | EL10044 | 96 wells |
| Human M-CSF ELISA Kit | EL10046 | 96 wells |
| Human TNF-β ELISA Kit | EL10047 | 96 wells |
| Human bFGF ELISA Kit | EL10048 | 96 wells |
| Human Alphafetoprotein (AFP) ELISA Kit | EL10049 | 96 wells |
| Human B2MG ELISA Kit | EL10051 | 96 wells |
| Human Carcinoembryonic Antigen (CEA) ELISA Kit | EL10052 | 96 wells |
| Human IL-17A ELISA Kit | EL10053 | 96 wells |
| Human IL-13 ELISA Kit | EL10054 | 96 wells |
| Human IL-22 ELISA Kit | EL10055 | 96 wells |
| Human IL-9 ELISA Kit | EL10056 | 96 wells |
| Human Amyloid Beta Peptide 42 ELISA Kit | EL10057 | 96 wells |
| Human Programmed Death-Ligand 1 (PD-L1) ELISA Kit | EL10058 | 96 wells |
| Human Programmed Death-1 (PD-1) ELISA Kit | EL10059 | 96 wells |
| Human IL-18 ELISA Kit | EL10060 | 96 wells |
| Multiplex Human Cytokine ELISA Kit (Inflammatory) | EM10001 | 96 wells |
| Multiplex Human Cytokine ELISA Kit (M1/M2/MDSC Cytokines) | EM10002 | 96 wells |
| Multiplex Human Cytokine ELISA Kit (Th1/Th2/Th17) | EM10003 | 96 wells |
| Mouse IL-17A ELISA Kit | MEC1001 | 96 wells |
| Mouse IFN-γ ELISA Kit | MEC1002 | 96 wells |
| Mouse TNF-α ELISA Kit | MEC1003 | 96 wells |
| Mouse GM-CSF ELISA Kit | MEC1004 | 96 wells |
| Mouse MCP-1 ELISA Kit | MEC1005 | 96 wells |
| Mouse IL-2 ELISA Kit | MEC1006 | 96 wells |
| Mouse IL-5 ELISA Kit | MEC1007 | 96 wells |
| Mouse IL-6 ELISA Kit | MEC1008 | 96 wells |
| Mouse IL-4 ELISA Kit | MEC1009 | 96 wells |
| Mouse IL-1β ELISA Kit | MEC1010 | 96 wells |
| Mouse IL-1α ELISA Kit | MEC1011 | 96 wells |
| Mouse TGF-β1 ELISA Kit | MEC1012 | 96 wells |
| pAb anti-Human CRP, Tracer (HRP Labeled) | AI20009P | 0.2 mL |
| mAb anti-Human TNF-α, CH8820, Capture | MO-C40003B | 0.1 mg |
| mAb anti-Human TNF-α, B1E4, Detector | MO-C40003E | 0.1 mg |
| mAb anti-Human TNF-α, B1E4, Tracer (HRP Labeled) | MO-C40003T | 0.2 mL |
| mAb anti-Human TNF-α, B1E4, Tracer (Biotin Labeled) | MO-C40003TB | 0.1 mL |
| mAb anti-Human IL-8, I8-S2, Capture | MO-C40017A | 0.1 mg |
| mAb anti-Human IL-8, I8-60, Detector | MO-C40017D | 0.1 mg |
| mAb anti-Human IL-8, I8-60, Tracer (HRP Labeled) | MO-C40017T | 0.2 mL |
| mAb anti-Human IL-8, I8-60, Tracer (Biotin Labeled) | MO-C40017TB | 0.1 mL |
| mAb anti-Human MCP-1, S14, Capture | MO-C40021B | 0.1 mg |
| mAb anti-Human MCP-1, S101, Detector | MO-C40021D | 0.1 mg |
| mAb anti-Human MCP-1, S101, Tracer (HRP Labeled) | MO-C40021T | 0.2 mL |
| mAb anti-Human MCP-1, S101, Tracer (Biotin Labeled) | MO-C40021TB | 0.1 mL |
| mAb anti-Human SAA, 115, Capture | MO-C40028A | 0.1 mg |
| mAb anti-Human SAA, 607, Detector | MO-C40028E | 0.1 mg |
| mAb anti-Human SAA, 607, Tracer (HRP Labeled), 0.2mL | MO-C40028T | 0.2 mL |
| mAb anti-Human SAA, 607, Tracer (Biotin Labeled), 0.1mL | MO-C40028TB | 0.1 mL |
| mAb anti-Human EGF, S-134, Capture | MO-C40044D | 0.1 mg |
| mAb anti-Human EGF, S-146, Detector | MO-C40044F | 0.1 mg |
| mAb anti-Human EGF, S-146, Tracer (HRP Labeled) | MO-C40044T | 0.2 mL |
| mAb anti-Human EGF, S-146, Tracer (Biotin Labeled) | MO-C40044TB | 0.1 mL |
| mAb anti-Human MCP-3, 113, Detector | MO-C40088A | 0.1 mg |
| mAb anti-Human MCP-3, 542, Capture | MO-C40088G | 0.1 mg |
| mAb anti-Human MCP-3, 113, Tracer (HRP Labeled) | MO-C40088T | 0.2 mL |
| mAb anti-Human MCP-3, 113, Tracer (Biotin Labeled) | MO-C40088TB | 0.1 mL |
| mAb anti-Human IL-16, 323, Detector | MO-C40089J | 0.1 mg |
| mAb anti-Human IL-16, 398, Capture | MO-C40089K | 0.1 mg |
| mAb anti-Human IL-16, 323, Tracer (HRP Labeled) | MO-C40089T | 0.2 mL |
| mAb anti-Human GM-CSF, 59, Capture | MO-C40090B | 0.1 mg |
| mAb anti-Human GM-CSF, 429, Detector | MO-C40090D | 0.1 mg |
| mAb anti-Human GM-CSF, 429, Tracer (HRP Labeled) | MO-C40090T | 0.2 mL |
| mAb anti-Human GM-CSF, 429, Tracer (Biotin Labeled) | MO-C40090TB | 0.1 mL |
| mAb anti Human IL-18 clone 2A10, Capture | MO-C40094A | 0.1mg |
| mAb anti Human IL-18 clone 10H4, Detector | MO-C40094B | 0.1mg |
| mAb anti human IL-18 clone 10H4, Tracer (Biotin Labeled) | MO-C40094TB | 0.1 mL |
| mAb anti Human IL-15 clone 5E8, Capture | MO-C40095A | 0.1mg |
| mAb anti Human IL-15 clone B1H6, Detector | MO-C40095B | 0.1mg |
| mAb anti human IL-15 clone B1H6, Tracer (Biotin labeled) | MO-C40095TB | 0.1 mL |
| mAb anti-HIV-1 P24 (Core Protein), 473, Detector | MO-I40002A | 0.1 mg |
| mAb anti-HIV-1 P24 (Core Protein), 340, Capture | MO-I40002D2 | 0.1 mg |
| mAb anti-HIV-1 P24 (Core Protein), 473, Tracer (HRP), 0.2 mL | MO-I40002T2 | 0.2 mL |
| mAb anti-Human PD-1 / CD279, 7G12, Tracer (Biotin labeled) | MO-L40043TB | 0.1 mL |
| mAb anti Human PD-L1 clone 12B4, Detector | MO-L40044I | 0.1 mg |
| mAb anti Human PD-L1 clone 15G3, Capture | MO-L40044N | 0.1 mg |
| mAb anti human PD-L1 clone 12B4, Tracer (Biotin Labeled) | MO-L40044TB | 0.1 mL |
| mAb anti-hGH, YC6, Capture | MO-M40012A | 0.1 mg |
| mAb anti-hGH, YC8, Tracer (HRP Labeled), 0.2 mL | MO-M40012T | 0.2 mL |
| mAb anti-hGH, YC8, Tracer (Biotin Labeled), 0.1 mL | MO-M40012TB | 0.1 mL |
| mAb anti-Human B2MG, D2E9, Capture | MO-M40021C | 0.1 mg |
| mAb anti-Human B2MG, D3A2, Detector | MO-M40021F | 0.1 mg |
| mAb anti-Human B2MG, D3A2, Tracer (HRP Labeled), 0.2mL | MO-M40021T | 0.2 mL |
| mAb anti-human CRP, 63F4, Capture | MO-M40023A | 0.1 mg |
| mAb anti-human TSH, TSH-2, Detector | MO-M40046A | 0.1 mg |
| mAb anti-human TSH, TSH-1, Capture | MO-M40046B | 0.1 mg |
| mAb anti-human TSH, TSH-2, Tracer (HRP Labeled), 0.2 mL | MO-M40046T | 0.2 mL |
| mAb anti-Human Prolactin, PRL-1, Capture | MO-M40047B | 0.5 mg |
| mAb anti-Human Prolactin, PRL-2, Tracer (HRP Labeled), 0.2 mL | MO-M40047T | 0.2 mL |
| mAb anti-Human LH, LH-1, Capture | MO-M40048B | 0.5 mg |
| mAb anti-Human LH, LH-2, Tracer (HRP Labeled), 0.2 mL | MO-M40048T | 0.2 mL |
| mAb anti-hCG, HCG-1, Capture | MO-M40049B | 0.5 mg |
| mAb anti-hCG, HCG-2, Tracer (HRP Labeled), 0.2 mL | MO-M40049T | 0.2 mL |
| mAb anti-Human FSH, FSH-1, Capture | MO-M40050B | 0.5 mg |
| mAb anti-Human FSH, FSH-2, Tracer (HRP Labeled) | MO-M40050T | 0.2 mL |
| mAb anti-Amyloid β Peptide 42, CA9 10C11, Detector | MO-M40093B | 0.5 mg |
| mAb anti-Amyloid β Peptide 42, CA9 10C11, Tracer (Biotin) | MO-M40093TB | 0.1 mL |
| mAb anti-Amyloid β Peptide N-terminal, NT 5B8, Capture | MO-M40094D | 0.5 mg |
| mAb anti-Amyloid β Peptide 40, CV9 7B10, Detector | MO-M40095A | 0.1 mg |
| mAb anti-Amyloid β Peptide 40, CV9 7B10, Tracer (Biotin) | MO-M40095TB | 0.1 mL |
| mAb anti-Human AFP, AFP-Y2, Detector | MO-T40007A | 0.1 mg |
| mAb anti-Human AFP, AFP-Y1, Capture | MO-T40007B | 0.1 mg |
| mAb anti-Human AFP, AFP-2, Tracer (HRP Labeled), 0.2 mL | MO-T40007T | 0.2 mL |
| mAb anti-Human CEA, CEA-Y2, Detector | MO-T40051A | 0.1 mg |
| mAb anti-Human CEA, CEA-Y1, Capture | MO-T40051B | 0.1 mg |
| mAb anti-Human CEA, CEA-Y2, Tracer (HRP Labeled), 0.2 mL | MO-T40051T | 0.2 mL |
| mAb anti-Human Free PSA, 103, Detector | MO-T40052A | 0.1 mg |
| mAb anti-Human Free PSA, 108, Capture | MO-T40052B | 0.1 mg |
| mAb anti-Human Free PSA, 103, Tracer (HRP Labeled), 0.2 mL | MO-T40052T | 0.2 mL |
| mAb anti-Human PSA, CHYH1, Capture | MO-T40081A | 0.1 mg |
| mAb anti-Human PSA, CHYH2, Dectector | MO-T40081B | 0.1 mg |
| mAb anti-Human PSA, CHYH2, Tracer (HRP Labeled), 0.2 mL | MO-T40081T | 0.2 mL |
| Human Chorionic Gonadotrophin (hCG), 10 mg | AP30002 | 10 mg |
| Human Immunoglobulin G (IgG), 10 mg | IG30001 | 10 mg |
| Mouse Immunoglobulin G (IgG), 10 mg | IG41002 | 10 mg |
| Mouse Immunoglobulin G2b (IgG2b), 10 mg | IG41004 | 10 mg |
| Rat Immunoglobulin G (IgG) | IG42003 | 10 mg |
| Human Umbilical Cord Serum, 10 mL | S30010 | 10 mL |
| ELISA Coating (EC) Stabilizer, 500 mL | S7001 | 500 mL |
| Human IL-8 Matched Antibody Pair for ELISpot | SL10008A | 5 × 96 wells |
| Human IL-8 Development Set for ELISpot | SL10008B | 5 × 96 wells |
| Human IL-8 ELISpot Kit | SL10008E | 6 X 96 wells |
| Human MCAF (MCP-1) Matched Antibody Pair for ELISpot | SL10009A | 5 × 96 wells |
| Human MCAF (MCP-1) Development Set for ELISpot | SL10009B | 5 × 96 wells |
| Human MCAF (MCP-1) ELISpot Kit | SL10009E | 6 X 96 wells |
| Human GM-CSF Matched Antibody Pair for ELISpot | SL10020A | 5 × 96 wells |
| Human GM-CSF Development Set for ELISpot | SL10020B | 5 × 96 wells |
| Human GM-CSF ELISpot Kit | SL10020E | 6 X 96 wells |
| Human IFN-γ Matched Antibody Pair for ELISpot | SL10024A | 5 × 96 wells |
| Human IFN-γ Development Set for ELISpot | SL10024B | 5 × 96 wells |
| Human IFN-γ ELISpot Kit | SL10024E | 6 X 96 wells |
| Human IL-12 (P70) ELISpot Kit | SL10032E | 6 X 96 wells |
| TMB Solution (500 mL Part A & 500 mL Part B) | SU6006 | 1.0 L |
| pAb Rabbit anti-HCV Virus, 1.0 mg | AI20006P | 1.0 mg |
| pAb Rabbit anti-HIV-1 p24, 1.0 mg | AI20008P | 1.0 mg |
| pAb anti-Human CRP, Tracer (HRP Labeled) | AI20009P | 0.2 mL |
| pAb Rabbit anti-Mouse IgG , 1.0 mg | AI50005 | 1.0 mg |
| pAb Rabbit anti-Mouse IgG - HRP Conjugated, 1.0 mL | AI50005P | 1.0 mL |
| pAb Rabbit anti-hGH, | AI50006P | 1.0 mg |
| pAb Chicken anti-human IL-8 (IgY fraction) | AI60001 | 1.0 mg |
| pAb Rabbit anti-Human FPRL-1 2nd Extracellular Loop | AI70001A | 0.1 mg |
| pAb Rabbit anti-Human FPRL-1 C-terminal | AI70001B | 0.1 mg |
| pAb Rabbit anti-Human PML [Ring Finger Domain] | AI70002A | 0.1 mg |
| pAb Rabbit anti-Human PML [B-box 1 domain] | AI70002B | 0.1 mg |
| pAb Rabbit anti-Bcl-2 | AI70003A | 0.1 mg |
| pAb Rabbit anti-Phospho-Bcl-2 (Thr56) | AI70003B | 0.1 mg |
| pAb Rabbit anti-Phospho-Bcl-xL (Thr115) | AI70003D | 0.1 mg |
| pAb Rabbit anti-Phospho c-kit (Tyr719) | AI70004A | 0.1 mg |
| pAb Rabbit anti-Phospho IKK-γ (Ser31) | AI70005A | 0.1 mg |
| pAb Rabbit anti-NF-κB-p65 (RelA) | AI70006A | 0.1 mg |
| pAb Rabbit anti-Phospho-NF-қB-p65 (Ser276) | AI70007A | 0.1 mg |
| pAb Rabbit anti-Phospho-NF-қB-p65 (Ser468) | AI70008A | 0.1 mg |
| pAb Rabbit anti-Phospho NF-қB-p105/p50 (Ser337) | AI70009A | 0.1 mg |
| pAb Rabbit anti-Human Serum Albumin (HSA) | AI80001 | 0.1 mg |
| pAb Rabbit anti-Human Fibrinogen, 0.1 mg | AI80002 | 0.1 mg |
| pAb Rabbit anti-Human Transferrin | AI80003 | 0.1 mg |
| pAb Rabbit anti-Human IgA, 0.5 mg | AI80004 | 0.5 mg |
| pAb Rabbit anti-human IgM, 0.5 mg | AI80005 | 0.5 mg |
| pAb Rabbit anti-Human TREK-1 (K2p2.1) | AI80006A | 0.1 mg |
| pAb Rabbit anti-Mouse Kchip1 | AI80007 | 0.1 mg |
| pAb Rabbit anti-Mouse Kchip4 | AI80008 | 0.1 mg |
| pAb Rabbit anti-Mouse Kv4.3 | AI80010A | 0.1 mg |
| pAb Rabbit anti-Mouse TRPV1 | AI80011A | 0.1 mg |
| pAb Rabbit anti-Mouse TRPV3 | AI80012A | 0.1 mg |
| pAb Rabbit anti-Human JAK2 | AI80013A | 0.1 mg |
| pAb Rabbit anti-Human Glutathione S Transferase (GST), 0.1 mg | AI80014 | 0.1 mg |
| pAb Rabbit anti-Human Amyloid beta peptide 42 | AI90001 | 0.1 mg |
| pAb Rabbit anti-Human Amyloid beta peptide 43 | AI90002 | 0.1 mg |

Kalen Biomedical为全世界范围内的心血管研究机构提供一流品质的脂蛋白(lipoprotein)。通过制定严格的生产流程和高标准的质控体系,Kalen Biomedical能够保证产品品质的持续稳定性。Kalen Biomedical的产品线包括天然的人类脂蛋白,氧化和乙酰化的低密度脂蛋白,此外还有脂蛋白探针、脂蛋白缺失血清和培养基。
Kalen Biomedical, LLC provides premium quality lipoproteins for the international cardiovascular research community. Kalen has developed stringent manufacturing procedures and Quality Control to ensure our products perform consistently.
Kalen’s lipoprotein product line includes native human lipoproteins and oxidized and acetylated Low Density Lipoproteins (LDL). Our lipoprotein probes offer the convenience of fluorescence or biotin labeled LDL. We supply lipoprotein depleted serum media supplement for specialized cell cultures (shipment to North America only).
Kalen Biomedical的主要产品包括:
Native Lipoproteins
Acetylated Lipoproteins
Oxidized Lipoproteins
Labeled Lipoproteins
Lipoprotein Depleted Sera
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
< " data-original="http://plant.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Kalen Biomedical"> Kalen Biomedical
艾美捷科技代理美国Ran Biotechnologies公司全系列表面活性剂产品。
NEAT FLUOROSURFACTANTS
Neat (un-dissolved) 008-FluoroSurfactant
1g (cat#: 008-FluoroSurfactant-1G)
5g (cat#: 008-FluoroSurfactant-5G)
10g (cat#: 008-FluoroSurfactant-10G)
50g (cat#: 008-FluoroSurfactant-50G)
100g (cat#: 008-FluoroSurfactant-100G)
0.5kg (cat#: 008-FluoroSurfactant-500G)
1kg (cat#: 008-FluoroSurfactant-1000G)
FLUOROSURFACTANTS IN SOLUTIONS
008-FluoroSurfactant dissolved in common fluorinated oils (e.g. HFE7500, FC40)
Sample size, choice of oil and surfactant concentration vary, depending on customer requests. Most commonly, solutions are supplied as 2 weight % or 5 weight % either in HFE7500 or FC40:
50g of 2 weight % 008-FluoroSurfactant in HFE7500 (cat#: 008-FluoroSurfactant-2wtH-50G)
50g of 2 weight % 008-FluoroSurfactant in FC40 (cat#: 008-FluoroSurfactant-2wtF-50G)
500g of 2 weight % 008-FluoroSurfactant in HFE7500 (cat#: 008-FluoroSurfactant-2wtH-500G)
500g of 2 weight % 008-FluoroSurfactant in FC40 (cat#: 008-FluoroSurfactant-2wtF-500G)
20g of 5 weight % 008-FluoroSurfactant in HFE7500 (cat#: 008-FluoroSurfactant-5wtH-20G)
20g of 5 weight % 008-FluoroSurfactant in FC40 (cat#: 008-FluoroSurfactant-5wtF-20G)
200g of 5 weight % 008-FluoroSurfactant in HFE7500 (cat#: 008-FluoroSurfactant-5wtH-200G)
200g of 5 weight % 008-FluoroSurfactant in FC40 (cat#: 008-FluoroSurfactant-5wtF-200G)
FLUOROSURFACTANT KITS
“FS-Kit#1” contains:
10g of 5 weight % 008-FluoroSurfactant in HFE7500
10g of 5 weight % 008-FluoroSurfactant in FC40
50g of neat HFE7500
50g of neat FC40
“FS-Kit#2” contains:
1g neat 008-FluoroSurfactant
60g of neat HFE7500
60g of neat FC40
“NoChipDrop-Kit1” contains:
Emulsion Oil – 500microL
Aqueous Recovery Oil – 125microL
Gel Bead Slurry – 350microL
“NoChipDrop-Kit2” contains:
Emulsion Oil – 2.2mL
Aqueous Recovery Oil – 0.55mL
Gel Bead Slurry – 1.4mL
Fluorinated surfactants containing:
Fluorescein (cat# FluoreFS)
Rhodamine (cat# FS-Rhodamine)
Biotin (cat# FS-Biotin)
BenzylGuanine (cat# FS-BG)
Sugar (cat# FS-Sug)
< " data-original="http://plant.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Ran Biotechnologies全系列产品"> 艾美捷科技代理Ran Biotechnologies全系列产品
艾美捷科技代理Nexcelom品牌。
2003年,Nexcelom的创始人推出了CP2,这是一种辅助手动细胞计数的方便工具。Nexcelom的创始人兼首席技术官JeanQiu博士说,“NIH的某位客户曾要求我们‘消除显微镜计数’。
为此,我们发明了CellometerAutoT4,用于测量细胞浓度和活力。”自那时起,Nexcelom扩大了产品范围,升级了系统功能,并优化了适用的方法,使研究人员能够分析所有细胞类型,
包括小细胞和原代细胞。凭借先进的专有技术,Nexcelom是细胞分析中基于图像的细胞计数的领导者和创新者。世界各地的科学家在学术和政府研究机构、生物技术和工业环境中使用
Cellometer,Cellaca和Celigo仪器进行细胞定量、分析和基于细胞的检测。Nexcelom图像细胞术和细胞分析解决方案被集成到生命科学的广泛工作流程中。
< " data-original="http://plant.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Nexcelom品牌"> 艾美捷科技代理Nexcelom品牌
艾美捷科技代理Epitope Diagnostics全系列抗体及试剂盒产品。
Epitope Diagnostics是一家经过ISO 13845认证的医疗器械制造公司,位于圣地亚哥的索伦托谷生物技术中心。Epitope专门从事全球医疗设备和诊断行业的分析开发和制造。公司涉足领域包括胃肠道,心血管,感染和自身免疫性疾病,以及肿瘤/癌症和钙/骨代谢。Epitope Diagnostics Inc. (EDI) strives to develop, manufacture, and market the highest quality and most innovated in-vitro diagnostics (IVD) products to the global research, pharmaceutical, and healthcare community. We seek to become a major contributor in resolving the unmet medical needs of the world.
Epitope Diagnostics公司的主要产品包括:
| ANTIBODIES | ||
| MAB30699 | Anti-MMAE Monoclonal Antibody | |
| MAB30699b | Biotinylated Anti-MMAE Monoclonal Antibody | |
| MAB30700 | Anti-MMAF Monoclonal Antibody | |
| MAB30700b | Biotinylated Anti-MMAF Monoclonal Antibody | |
| 30698 | Anti-DM1 Polyclonal Antibody | |
| 30699 | Anti-MMAE Polyclonal Antibody | |
| 30700 | Anti-MMAE Polyclonal Antibody | |
| 30618 | Anti-Human FGF-21 N-terminal Specific Antibody, Affinity Purified | |
| 30661 | Anti-Human FGF-21 C-terminal Specific Antibody, Affinitiy Purified | |
| 30704 | Anti-Human Chromogranin A Monoclonal Antibody, Murine | |
| 30705 | Anti-Human Chromogranin A Polyclonal Antibody, Sheep | |
| 30706 | Anti-Human Chromogranin A N-terminal Polyclonal Antibody, Rabbit | |
| 30713 | Anti-Human Chromogranin A N/mid-regional Polyclonal Antibody, Rabbit | |
| 30714 | Anti-Human Chromogranin A C/mid-regional Polyclonal Antibody, Rabbit | |
| 30715 | Anti-Human Chromogranin A C-terminal Polyclonal Antibody, Rabbit | |
| 30657 | Anti-Human NGAL Polyclonal Antibody (IgG), Sheep | |
| 30658 | Anti-Human NGAL Polyclonal Antibody, Sheep, Affinity Purified | |
| TUMOR MARKERS & CANCER RESEARCH | ||
| KT-810 | Human Pepsinogen I ELISA Kit | 96 tests/kit |
| KT-811 | Human Pepsinogen II ELISA Kit | 96 tests/kit |
| KT-812 | Human Chromogranin A ELISA Kit (1st generation) | 96 tests/kit |
| KT-820 | Human Chromogranin A ELISA Kit (2nd generation) | 96 tests/kit |
| KT-855 | Human Chromogranin A ELISA Kit (2nd generation, wide range) | 96 tests/kit |
| KT-817 | Human Neuron Specific Enolase ELISA Kit | 96 tests/kit |
| KT-850 | q-FOB™ Quantitative Fecal Occult Blood Test ELISA Kit | 96 tests/kit |
| 30210 | Fecal Sample Collection Device for q-FOB™ | 50 tubes/kit |
| KT-111 | FOB Cassette Test Kit | 20 tests/kit |
| KT-705 | Intact Brentuximab Vedotin ELISA KIt | 96 tests/kit |
| KT-706 | Trastuzumab Emtansine EIA Kit | 96 tests/kit |
| KTR-755 | Humanized Anti-Her2/neu (Herceptin/trastuzumab) ELISA Kit | 96 tests/kit |
| KTR-756 | DM1 ADC EIA Kit | 96 tests/kit |
| KTR-757 | MMAE ADC EIA Kit | 96 tests/kit |
| KTR-758 | MMAF ADC EIA Kit | 96 tests/kit |
| KTR-782 | Intact MMAE ADC ELISA Kit | 96 tests/kit |
| KTR-783 | Intact MMAF ADC ELISA Kit | 96 tests/kit |
| GASTROINTESTINAL DISEASE-Serum ELISA Kits | ||
| KT-810 | Human Pepsinogen I ELISA Kit | 96 tests/kit |
| KT-811 | Human Pepsinogen II ELISA Kit | 96 tests/kit |
| KT-830 | Human Anti-Gliadin IgA EIA Kit | 96 tests/kit |
| KT-831 | Human Anti-Gliadin IgG EIA Kit | 96 tests/kit |
| KT-845 | Human Anti-Giardia lamblia IgA ELISA Kit | 96 tests/kit |
| KT-846 | Human Anti-Giardia lamblia IgG ELISA Kit | 96 tests/kit |
| KT-847 | Human Anti-Giardia lamblia IgM ELISA Kit | 96 tests/kit |
| GASTROINTESTINAL DISEASE-Fecal ELISA Kits | ||
| KT-824 | Qualitative Fecal H. pylori Antigen ELISA Kit | 96 tests/kit |
| KT-826 | Quantitative Fecal H. pylori Antigen ELISA Kit | 96 tests/kit |
| KT-828 | Fecal C. difficile GDH ELISA Kit | 96 tests/kit |
| KT-834 | Fecal C. difficile Toxin A ELISA Kit | 96 tests/kit |
| KT-835 | Fecal C. difficile Toxin B ELISA Kit | 96 tests/kit |
| KT-836 | Fecal C. difficile Toxin A & B ELISA Kit | 96 tests/kit |
| KT-837 | Fecal E. coli 0157 ELISA Kit | 96 tests/kit |
| KT-838 | Fecal Giardia lamblia Antigen ELISA Kit | 96 tests/kit |
| KT-839 | Fecal Cryptosporidium parvum Antigen ELISA Kit | 96 tests/kit |
| KT-841 | Fecal Rotavirus Antigen ELISA Kit | 96 tests/kit |
| KT-842 | Fecal Adenovirus Antigen ELISA Kit | 96 tests/kit |
| KT-849 | Quantitative Fecal Calprotectin ELISA Kit | 96 tests/kit |
| KT-850 | q-FOB™ Quantitative Fecal Occult Blood Test ELISA Kit | 96 tests/kit |
| KT-853 | Quantitative Fecal NGAL ELISA Kit | 96 tests/kit |
| KT-880 | Quantitative Fecal/Urine Myeloperoxidase ELISA Kit | 96 tests/kit |
| GASTROINTESTINAL DISEASE-Fecal Sample Collection Kits | ||
| KT-854 | Fecal H. pylori Sample Collection Kit | 50 tubes/kit |
| KT-864 | Fecal H. pylori/GDH/Toxin A&B Sample Collection Kit | 48 tubes/kit |
| KT-843 | Fecal Calprotectin Sample Collection Kit | 50 tubes/kit |
| 30210 | q-FOB™ Fecal Sample Collection Device | 50 tubes/kit |
| KT-844 | Fecal MPO Sample Collection Kit | 48 tubes/kit |
| KT-884 | Fecal NGAL Sample Collection Kit | 48 tubes/kit |
| FPC200 | Fecal Ova/Parasite Concentration Kit | 50 tubes/kit |
| GASTROINTESTINAL DISEASE-Rapid Tests | ||
| KT-313 | EpiTuub® Immunochemical Fecal Occult Blood Rapid Test Kit | 30 tests/kit |
| KT-917 | EpiTuub® Fecal Rotavirus Antigen Rapid Test Kit | 30 tests/kit |
| KT-918 | EpiTuub® Fecal Adenovirus Antigen Rapid Test Kit | 30 tests/kit |
| KT-920 | EpiTuub® Fecal Calprotectin Rapid Test Kit | 30 tests/kit |
| KT-921 | EpiTuub® Fecal Calprotectin Rapid Test Kit | 10 tests/kit |
| KT-922 | EpiTuub® Calprotectin/i-FOB DUO Test | 30 tests/kit |
| KT-926 | EpiTuub® Fecal Rota-Adeno Duo Antigen Rapid Test Kit | 30 tests/kit |
| KT-927 | EpiTuub® Fecal Giardia lamblia Antigen Rapid Test Kit | 30 tests/kit |
| KT-928 | EpiTuub® Fecal Cryptosporidiun parvum Antigen Rapid Test Kit | 30 tests/kit |
| KT-929 | EpiTuub® Fecal H. pylori Antigen Rapid Test Kit | 30 tests/kit |
| KT-935 | EpiTuub® Fecal C. difficile Antigen Rapid Test Kit | 30 tests/kit |
| GASTROINTESTINAL DISEASE-Strip Test Kit | ||
| KT-313s | Immunochemical Fecal Occult Blood Strip Test Kit | 50 strips/kit |
| KT-917s | Fecal Rotavirus Antigen Strip Test Kit | 50 strips/kit |
| KT-918s | Fecal Adenovirus Antigen Strip Test Kit | 50 strips/kit |
| KT-920s | Fecal Calprotectin Strip Test Kit | 50 strips/kit |
| KT-927s | Fecal Giardia lamblia Antigen Strip Test Kit | 50 strips/kit |
| KT-928s | Fecal Cryptosporidium parvum Antigen Strip Test Kit | 50 strips/kit |
| KT-929s | Fecal H. pylori Antigen Strip Test Kit | 50 strips/kit |
| KT-935s | Fecal C. difficile Antigen Strip Test Kit | 50 strips/kit |
| GASTROINTESTINAL DISEASE-Cassette Test Kits | ||
| KT-111 | FOB Cassette Test Kit | 20 tests/kit |
| KT-112 | Calprotectin Cassette Test Kit | 20 tests/kit |
| KT-113 | H. pylori Cassette Test Kit | 20 tests/kit |
| INFECTIOUS DISEASE | ||
| KT-851 | Varicella Zoster Virus (VZV) IgG ELISA Kit | 96 tests/kit |
| KT-867 | HAV IgG ELISA Kit | 96 tests/kit |
| KT-868 | HAV IgM ELISA Kit,μ-Capture Method | 96 tests/kit |
| KT-869 | Total HAV Antibody ELISA Kit | 96 tests/kit |
| KT-897 | Zika Virus IgG ELISA Kit | 96 tests/kit |
| KT-898 | Zika Virus IgM ELISA Kit,μ-Capture Method | 96 tests/kit |
| KT-1011 | HBeAg ELISA Kit | 96 tests/kit |
| KT-1015 | H. pylori IgG ELISA Kit | 96 tests/kit |
| KT-1018 | HEV IgG ELISA Kit | 96 tests/kit |
| KT-1019 | HEV IgM ELISA Kit,μ-Capture Method | 96 tests/kit |
| KTR-1020 | Toxoplasma gondii IgG ELISA Kit | 96 tests/kit |
| KTR-1021 | Toxoplasma gondii IgM ELISA Kit,μ-Capture Method | 96 tests/kit |
| KTR-1022 | Rubella IgG ELISA Kit | 96 tests/kit |
| KTR-1023 | Rubella IgM ELISA Kit,μ-Capture Method | 96 tests/kit |
| KTR-1024 | Cytomegalovirus (CMV) IgG ELISA Kit | 96 tests/kit |
| KTR-1025 | Cytomegalovirus (CMV) IgM ELISA Kit,μ-Capture Method | 96 tests/kit |
| KT-1026 | HSV 1+2 IgG ELISA Kit,μ-Capture Method | 96 tests/kit |
| KT-1027 | HSV 1+2 IgM ELISA Kit,μ-Capture Method | 96 tests/kit |
| KT-1028 | HSV-1 IgG ELISA Kit | 96 tests/kit |
| KT-1029 | HSV-1 IgM ELISA Kit,μ-Capture Method | 96 tests/kit |
| KT-1030 | HSV-2-IgG ELISA Kit | 96 tests/kit |
| KT-1031 | HSV-2 IgM ELISA Kit,μ-Capture Method | 96 tests/kit |
| KT-1032 | Coronavirus COVID-19 IgG ELISA Kit - qualitative, N protein target, CE marked | 96 tests/kit |
| KT-1033 | Coronavirus COVID-19 IgM ELISA Kit - qualitative, N protein target, CE marked | 96 tests/kit |
| KT-1034 | COVID-19 Nucleocapsid IgG Quantitative ELISA Kit - CE marked | 96 tests/kit |
| KTR-1035 | Quantitative SARS-CoV-2 Spike Protein IgG ELISA - CE marked | 96 tests/kit |
| KTR-1036 | Quantitative SARS-CoV-2 Neutralizing Antibody ELISA - CE marked | 96 tests/kit |
| CARDIOVASCULAR DISEASE | ||
| KT-800 | Human Fetuin-A ELISA Kit | 96 tests/kit |
| KT-900 | High Sensitive Human Fetuin-A ELISA Kit | 96 tests/kit |
| KT-883 | Human Plasma NGAL ELISA Kit | 96 tests/kit |
| KT-885 | Plasma Calprotectin ELISA Kit | 96 tests/kit |
| KT-890 | Quantitative Serum/Plasma Myeloperoxidase ELISA Kit | 96 tests/kit |
| CALCIUM/BONE METABOLISM | ||
| KT-809 | Human Osteocalcin (1-43/49) ELISA Kit | 96 tests/kit |
| KT-715 | Total 25-OH Vitamin D EIA Kit (Two wash steps) | 96 tests/kit |
| KT-815 | Total 25-OH Vitamin D EIA Kit (Three wash steps) | 96 tests/kit |
| KT-888 | Human Intact PTH ELISA Kit | 96 tests/kit |
| KT-896 | Human VDBP ELISA Kit | 96 tests/kit |
| KT-819 | Human Growth Hormone ELISA Kit | 96 tests/kit |
| KT-840 | Human Anti-CaSR IgG ELISA Kit | 96 tests/kit |
| ENDOCRINOLOGY/DIABETES | ||
| KT-804 | Human Anti-Müllerian Hormone ELISA Kit | 96 tests/kit |
| KT-809 | Human Osteocalcin (1-43/49) ELISA Kit | 96 tests/kit |
| KT-819 | Human Growth Hormone ELISA Kit | 96 tests/kit |
| KT-871 | Active GLP-1 (7-36) ELISA Kit | 96 tests/kit |
| KT-876 | Total GLP-1 ELISA Kit | 96 tests/kit |
| KT-602 | Total GLP-1 ELISA Kit | 96 tests/kit |
| KT-910 | GLP-1 Sample Solid Phase Extraction Kit | 50 columns/kit |
| KTR-873 | Human FGF-21 N-terminal specific ELISA Kit | 96 tests/kit |
| KTR-874 | Human FGF-21 C-terminal specific ELISA Kit | 96 tests/kit |
| KT-879 | Human Intact FGF-21 ELISA Kit | 96 tests/kit |
| KT-886 | Human Insulin ELISA Kit | 96 tests/kit |
| KT-887 | Human High Sensitive Insulin ELISA Kit | 96 tests/kit |
| KTR-888 | Human Intact PTH ELISA Kit | 96 tests/kit |
| KT-881 | Human C-peptide ELISA Kit | 96 tests/kit |
| KT-882 | Human ACTH ELISA Kit | 96 tests/kit |
| KT-891 | Human High Sensitive C-peptide ELISA Kit | 96 tests/kit |
| AUTOIMMUNE DISEASE | ||
| KT-802 | Human Anti-FcεRIα Autoantibody ELISA Kit | 96 tests/kit |
| KT-803 | Human Anti-IgE Autoantibody ELISA Kit | 96 tests/kit |
| KT-830 | Human Anti-Gliadin IgA EIA Kit | 96 tests/kit |
| KT-831 | Human Anti-Gliadin IgG EIA Kit | 96 tests/kit |
| KT-832 | Human Anti-Tg IgG ELISA Kit | 96 tests/kit |
| KT-833 | Human Anti-TPO IgG ELISA Kit | 96 tests/kit |
| KT-840 | Human Anti-CaSR IgG ELISA Kit | 96 tests/kit |
| MISCELLANEOUS KITS | ||
| KT-805 | HAMA (Human Anti-Mouse Antibody) ELISA Kit | 96 tests/kit |
| KT-806 | HAHA (Human Anti-Human Antibody) ELISA Kit | 96 tests/kit |
| KT-807 | MAHA (Mouse Anti-Human Antibody) ELISA Kit | 96 tests/kit |
| KT-751 | Haptoglobin Immunoturbidimetric Assay | Inquire |
<
更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://plant.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Epitope Diagnostics全系列抗体及试剂盒产品"> 艾美捷科技代理Epitope Diagnostics全系列抗体及试剂盒产品地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:18327026838
传真:15172469628
邮箱:sales@amyjet.com
0.4234